Document:

FORM OF AMENDED AND RESTATED 2011 OMNIBUS INCENTIVE PLAN

 Exhibit 10.7 
 TAYLOR & MARTIN GROUP, INC. 
 AMENDED AND RESTATED

 2011 OMNIBUS INCENTIVE PLAN 
 WHEREAS, Taylor & Martin Group, Inc. adopted the 2011 Omnibus Incentive Plan on May 8, 2012; and 
 WHEREAS, the Board of Directors considers it to be in the best interest of the Company to amend and restate the 2011 Omnibus Incentive Plan. 

NOW, THEREFORE, the Plan is amended and restated as follows: 

 

	1.	Purpose 

 The purposes of the
Taylor & Martin Group, Inc. 2011 Omnibus Incentive Plan (the “Plan”) are to (i) align the long-term financial interests of employees, directors, consultants, agents and other service providers of the Company and its
Subsidiaries with those of the Company’s stockholders; (ii) attract and retain those individuals by providing compensation opportunities that are competitive with other companies; and (iii) provide incentives to those individuals who
contribute significantly to the long-term performance and growth of the Company and its Subsidiaries. 
  

	2.	Term 

 (a) Effective
Date. The Plan was adopted by the Board on May 8, 2012, and approved by the sole stockholder of the Company on the same day, and shall become effective without further action as of the later of (a) the effectiveness of the
Company’s registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission on May 8, 2012 as amended (the “IPO Registration Statement”), and (b) the Common Stock being listed or approved for
listing upon notice of issuance on the New York Stock Exchange. 
 (b) Duration. Subject to the right of the Board to
amend or terminate the Plan at any time pursuant to Section 20 hereof, the Plan shall remain in effect until the earlier of (a) the date all shares of Common Stock subject to the Plan have been purchased or acquired according to the
Plan’s provisions or (b) the tenth anniversary of the date the Plan becomes effective pursuant to Section 2(a) hereof. No Awards shall be granted under the Plan after such termination date but Awards granted prior to such termination
date shall remain outstanding in accordance with their terms. 
  

	3.	Definitions 

 “Affiliate”
of any Person means any other Person directly or indirectly controlling, controlled by or under common control with such Person; provided that for purposes of this definition, “control” (including with correlative meanings, the terms
“controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person,
whether through the ownership of voting securities, by contract or otherwise. 
 “Award” shall mean an Option, SAR, Stock Award
or Cash Award granted under the Plan. 
 “Award Agreement” shall mean any written agreement, contract, or other instrument or
document evidencing an Award. 
 “Board” shall mean the Board of Directors of the Company. 

 “Cash Award” shall mean cash awarded under Section 7(d) of the Plan, including cash
awarded as a bonus or upon the attainment of Performance Criteria or otherwise as permitted under the Plan. 
 “Cause” shall
mean, unless otherwise specified in the Award Agreement, (i) a failure of the Participant to substantially perform his or her duties (other than as a result of physical or mental illness or injury); (ii) the Participant’s willful
misconduct or gross negligence; (iii) a material breach by the Participant of the Participant’s fiduciary duty or duty of loyalty to the Company or any Affiliate; (iv) the plea of guilty or nolo contendere by the Participant to
(or conviction of the Participant for the commission of) any felony or any other serious crime involving moral turpitude; (v) a material breach of the Participant’s obligations under any agreement entered into between the Participant and
the Company or any Affiliate; or (vii) a material violation of the Company’s written corporate governance guidelines, policies or procedures as specified in the Company’s Employee Handbook. 

“Change of Control” shall have the meaning set forth in Section 13. 
 “Code” shall mean the Internal Revenue Code of 1986, as amended, including any rules and regulations promulgated thereunder and any successor thereto. 

“Combination Transaction” shall have the meaning set forth in Section 6(a). 

“Committee” shall mean the Board or a committee designated by the Board to administer the Plan. With respect to Awards granted to
Covered Employees (or individuals expected to become Covered Employees), such committee shall consist of two or more individuals, each of whom, unless otherwise determined by the Board, is an “outside director” within the meaning of
Section 162(m) of the Code and a “nonemployee director” within the meaning of Rule 16b-3 of the Exchange Act. 
 “Common
Stock” shall mean the common stock of the Company, par value $0.00001 per share. 
 “Company” shall mean
Taylor & Martin Group, Inc., a Delaware corporation. 
 “Covered Employee” shall mean a “covered employee,”
as such term is defined in Section 162(m)(3) of the Code. 
 “Deferred Stock” shall mean an Award payable in shares of
Common Stock at the end of a specified deferral period that is subject to the terms, conditions and limitations described or referred to in Section 7(c)(iv). 
 “Disability” shall, unless otherwise provided in an Award Agreement, mean that the Participant is unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months; provided, that, if applicable to the Award, “Disability” shall
be determined in a manner consistent with Section 409A of the Code. 

  
 -2-

 “Eligible Recipient” shall mean (i) any employee (including any officer) of the
Company or any Subsidiary, (ii) any director of the Company or any Subsidiary or (iii) any individual performing services for the Company or a Subsidiary in the capacity of a consultant or otherwise. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder
and any successor thereto. 
 “Fair Market Value” shall mean, with respect to Common Stock or other property, the fair market
value of such Common Stock or other property determined by such methods or procedures as shall be established from time to time by the Committee. Unless otherwise determined by the Committee in good faith, the per share Fair Market Value of Common
Stock as of a particular date shall mean (i) the closing price per share of Common Stock on the national securities exchange on which the Common Stock is principally traded, for the last preceding date on which there was a sale of such Common
Stock on such exchange, or (ii) if the shares of Common Stock are then traded in an over-the-counter market, the average of the closing bid and asked prices for the shares of Common Stock in such over-the-counter market for the last preceding
date on which there was a sale of such Common Stock in such market, or (iii) if the shares of Common Stock are not then listed on a national securities exchange or traded in an over-the-counter market, such value as the Committee, in its sole
discretion, shall determine. 
 “ISO” shall mean an Option intended to be and designated as an incentive stock option within
the meaning of Section 422 of the Code. 
 “Nonqualified Stock Option” shall mean an Option that is granted to a
Participant that is not designated as an ISO. 
 “Option” shall mean the right to purchase a specified number of shares of
Common Stock at a stated exercise price for a specified period of time subject to the terms, conditions and limitations described or referred to in Section 7(a). The term “Option” as used in the Plan includes the terms
“Nonqualified Stock Option” and “ISO.” 
 “Participant” shall mean an Eligible Recipient who has been
granted an Award under the Plan. 
 “Performance Criteria” shall mean performance criteria based on the attainment by the
Company or any Subsidiary (or any division or business unit of such entity) of performance measures pre-established by the Committee in its sole discretion, based on one or more of the following: (1) return on total stockholder equity;
(2) earnings per share of Common Stock; (3) net income (before or after taxes); (4) earnings before any or all of interest, taxes, minority interest, depreciation and amortization; (5) sales or revenues; (6) return on
assets, capital or investment; (7) market share; (8) cost reduction goals; (9) implementation or completion of critical projects or processes; (10) cash flow; (11) gross or net profit margin; (12) achievement of
strategic goals; (13) growth and/or performance of the Company’s sales force; (14) operating service levels; and (15) any combination of, or a specified increase in, any of the foregoing. The Performance Criteria may be based
upon the attainment of specified levels of performance under one or more of the measures described above relative to the performance of other entities. To the extent permitted under Section 162(m) of the Code (including, without limitation,
compliance with any requirements for stockholder approval) or to the extent that an Award is not intended to 

  
 -3-

 
qualify as “performance-based compensation” under Section 162(m) of the Code, the Committee in its sole discretion may designate additional business criteria on which the
Performance Criteria may be based or adjust, modify or amend the aforementioned business criteria. Performance Criteria may include a threshold level of performance below which no Award will be earned, a level of performance at which the target
amount of an Award will be earned and a level of performance at which the maximum amount of the Award will be earned. The Committee, in its sole discretion, shall make equitable adjustments to the Performance Criteria in recognition of unusual or
non-recurring events affecting the Company or any Subsidiary or the financial statements of the Company or any Subsidiary, in response to changes in applicable laws or regulations, including changes in generally accepted accounting principles, or to
account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment of a business or related to a change in accounting principles, as applicable.

 “Person” shall have the meaning set forth in Section 14(d)(2) of the Exchange Act. 

“Plan Administrator” shall have the meaning set forth in Section 10. 
 “Restricted Stock” shall mean an Award of Common Stock that is subject to the terms, conditions, restrictions and limitations described or referred to in Section 7(c)(iii).

 “SABA” means SABA Group, LLC, a Texas limited liability company, and its Affiliates. 

“SAR” shall mean a stock appreciation right that is subject to the terms, conditions, restrictions and limitations described or referred
to in Section 7(b). 
 “Section 16(a) Officer” shall mean an Eligible Recipient who is subject to the reporting
requirements of Section 16(a) of the Exchange Act. 
 “Separation from Service” shall have the meaning set forth in
Section 1.409A-l(h) of the Treasury Regulations. 
 “Specified Employee” shall have the meaning set forth in
Section 409A of the Code and the Treasury Regulations promulgated thereunder. 
 “Stock Award” shall have the meaning set
forth in Section 7(c)(i). 
 “Stock Payment” shall mean a stock payment that is subject to the terms, conditions, and
limitations described or referred to in Section 7(c)(ii). 
 “Stock Unit” shall mean a stock unit that is subject to the
terms, conditions and limitations described or referred to in Section 7(c)(v). 
 “Subsidiary” means any corporation
(other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations (other than the last corporation) in the unbroken chain owns stock possessing 50 percent or more of the total combined voting power
of all classes of stock in one of the other corporations in the chain (or such lesser percent as is permitted by Section 1.409A-l(b)(5)(iii)(E) of the Treasury Regulations). 

  
 -4-

 “Treasury Regulations” shall mean the regulations promulgated under the Code by the United
States Internal Revenue Service, as amended. 
  

	4.	Administration 

 (a)
Committee Authority. The Committee shall have full and exclusive power to administer and interpret the Plan, to grant Awards and to adopt such administrative rules, regulations, procedures and guidelines governing the Plan and the Awards as
it deems appropriate, in its sole discretion, from time to time. The Committee’s authority shall include, but not be limited to, the authority to (i) determine the type of Awards to be granted under the Plan; (ii) select Award
recipients and determine the extent of their participation; (iii) determine Performance Criteria no later than such time as required to ensure that an underlying Award which is intended to comply with Section 162(m) of the Code so
complies; and (iv) establish all other terms, conditions, and limitations applicable to Awards, Award programs and, if applicable, the shares of Common Stock issued pursuant thereto. The Committee may accelerate or defer the vesting or payment
of Awards, cancel or modify outstanding Awards, waive any conditions or restrictions imposed with respect to Awards or the Common Stock issued pursuant to Awards and make any and all other determinations that it deems appropriate with respect to the
administration of the Plan, subject to (A) the limitations contained in Section 4(d) of the Plan and Section 409A of the Code with respect to all Participants and (B) the provisions of Section 162(m) of the Code with respect
to Covered Employees to the extent that an Award is intended to qualify as “performance-based compensation” under Section 162(m) of the Code. 
 (b) Administration of the Plan. The administration of the Plan shall be managed by the Committee. All determinations of the Committee shall be made by a majority of its members either present in
person or participating by conference telephone at a meeting or by written consent. The Committee shall have the power to prescribe and modify the forms of Award Agreement, correct any defect, supply any omission or clarify any inconsistency in the
Plan and/or in any Award Agreement and take such actions and make such administrative determinations that the Committee deems appropriate in its sole discretion. Any decision of the Committee in the administration of the Plan, as described herein,
shall be final, binding and conclusive on all parties concerned, including the Company, its stockholders and Subsidiaries and all Participants. 
 (c) Delegation of Authority. To the extent permitted by applicable law, the Committee may at any time delegate to one or more officers or directors of the Company some or all of its authority over
the administration of the Plan, with respect to individuals who are not Section 16(a) Officers or Covered Employees. 
 (d)
Prohibition Against Repricing. Except as set forth in Section 6(e) hereof, the terms of outstanding Awards may not be amended to reduce the exercise price of outstanding Options or SARs or cancel outstanding Options or SARs in exchange
for cash, other Awards, or Options and SARs with an exercise price that is less than the exercise price of the original Options or SARs without shareholder approval. 

  
 -5-

 (e) Indemnification. No member of the Committee or any other Person to whom any duty
or power relating to the administration or interpretation of the Plan has been delegated shall be personally liable for any action or determination made with respect to the Plan, except for his or her own willful misconduct or as expressly provided
by statute. The members of the Committee and its delegates, including any employee with responsibilities relating to the administration of the Plan, shall be entitled to indemnification and reimbursement from the Company, to the extent permitted by
applicable law and the By-laws and policies of the Company. In the performance of its functions under the Plan, the Committee (and each member of the Committee and its delegates) shall be entitled to rely upon information and advice furnished by the
Company’s officers, accountants, counsel and any other party they deem appropriate, and neither the Committee nor any such Person shall be liable for any action taken or not taken in reliance upon any such advice. 

 

	5.	Participation 

 (a)
Eligible Employees. Subject to Section 7 hereof, the Committee shall determine, in its sole discretion, which Eligible Recipients shall be granted Awards under the Plan. 

(b) Participation outside of the United States. In order to facilitate the granting of Awards to Employees who are foreign
nationals or who are employed outside of the U.S., the Committee may provide for such special terms and conditions, including, without limitation, substitutes for Awards, as the Committee may consider necessary or appropriate to accommodate
differences in local law, tax policy or custom. The Committee may approve any supplements to, or amendments, restatements or alternative versions of, this Plan as it may consider necessary or appropriate for the purposes of this Section 5(b)
without thereby affecting the terms of this Plan as in effect for any other purpose, and the appropriate officer of the Company may certify any such documents as having been approved and adopted pursuant to properly delegated authority; provided,
that no such supplements, amendments, restatements or alternative versions shall include any provisions that are inconsistent with the intent and purpose of this Plan, as then in effect; and further provided that any such action taken with respect
to a Covered Employee shall be taken in compliance with Section 162(m) of the Code to the extent that an Award is intended to qualify as “performance-based compensation” under Section 162(m) of the Code and that any such action
taken with respect to an Employee who is subject to Section 409A of the Code shall be taken in compliance with Section 409A of the Code. 
  

	6.	Available Shares of Common Stock 

 (a) Shares Subject to the Plan. Common Stock issued pursuant to Awards granted under the Plan may be shares that have been authorized but unissued, or have been previously issued and reacquired by
the Company, or both. Reacquired shares of Common Stock may consist of shares purchased in open market transactions or otherwise. Subject to the following provisions of this Section 6, the aggregate number of shares of Common Stock that may be
issued to Participants pursuant to Awards shall not exceed an aggregate of 5,000,000 shares of Common Stock, of which 1,000,000 shares may be granted as ISOs. The foregoing aggregate number also includes all shares that are intended to be issued on
the Effective Date in the form of Restricted Stock, the lapse of forfeiture restrictions with respect to which will be conditioned upon continued employment or Performance Criteria, to Eligible Recipients, in connection with the consummation of the
transactions described in the IPO Registration Statement (the “Combination Transaction”). 

  
 -6-

 (b) Forfeited and Expired Awards. Awards (or a portion of an Award) made under the
Plan which, at any time, are forfeited, expire or are canceled or settled without issuance of shares of Common Stock (collectively, the “Forfeited Shares”) shall not count towards the maximum number of shares that may be issued
under the Plan as set forth in Section 6(a) and shall be available for future Awards under the Plan. Notwithstanding the foregoing, any and all shares of Common Stock that are (i) tendered in payment of an Option exercise price (whether by
attestation or by other means); (ii) withheld by the Company to satisfy any tax withholding obligation; (iii) repurchased by the Company with Option exercise proceeds; (iv) covered by an SAR (to the extent that it is exercised and
settled in shares of Common Stock, without regard to the number of shares of Common Stock that are actually issued to the Participant upon exercise); or (v) Forfeited Shares that were issued as Restricted Stock in the Combination Transaction
shall be considered issued pursuant to the Plan and shall not be added to the maximum number of shares that may be issued under the Plan as set forth in Section 6(a). 
 (c) Other Items Not Included in Allocation. The maximum number of shares that may be issued under the Plan as set forth in Section 6(a) shall not be affected by (i) the payment in cash of
dividends or dividend equivalents in connection with outstanding Awards; (ii) the granting or payment of stock-denominated Awards that by their terms may be settled only in cash or the granting of Cash Awards; or (iii) Awards that are
granted in connection with a transaction between the Company or a Subsidiary and another entity or business in substitution or exchange for, or conversion adjustment, assumption or replacement of, awards previously granted by such other entity to
any individuals who have become Eligible Recipients as a result of such transaction. 
 (d) Other Limitations on Shares that
May be Granted under the Plan. Subject to Section 6(e), the aggregate number of shares of Common Stock that may be granted to any Covered Employee during a calendar year in the form of Options, SARs, and/or Stock Awards intended to qualify
as “performance-based compensation” under Section 162(m) of the Code shall not exceed 250,000 shares. Determinations made under this Section 6(d) with respect to Covered Employees shall be made in a manner consistent with
Section 162(m) of the Code. 
 (e) Adjustments. In the event of any change in the Company’s capital structure,
including, but not limited to, a change in the number of shares of Common Stock outstanding, on account of (i) any stock dividend, stock split, reverse stock split or any similar equity restructuring or (ii) any combination or exchange of
equity securities, merger, consolidation, recapitalization, reorganization, or divesture or any other similar event affecting the Company’s capital structure, to reflect such change in the Company’s capital structure, the Committee shall
make appropriate equitable adjustments to the maximum number of shares of Common Stock that may be issued under the Plan as set forth in Section 6(a) and to the maximum number of shares that may be granted to any single individual pursuant to
Section 6(d). In the event of any extraordinary dividend, divestiture or other distribution (other than ordinary cash dividends) of assets to stockholders, or any transaction or event described above, to the extent necessary to prevent the
enlargement or diminution of the rights of Participants, the Committee shall make appropriate equitable adjustments to the number or kind of shares subject to an outstanding 

  
 -7-

 
Award, the exercise price applicable to an outstanding Award (subject to the limitation contained in Section 4(d), and/or any measure of performance that relates to an outstanding Award,
including any applicable Performance Criteria. Any adjustment to ISOs under this Section 6(e) shall be made only to the extent not constituting a “modification” within the meaning of Section 424(h)(3) of the Code, and any
adjustments under this Section 6(e) shall be made in a manner that does not adversely affect the exemption provided pursuant to Rule 16b-3 under the Exchange Act. With respect to Awards subject to Section 409A of the Code, any adjustments
under this Section 6(e) shall conform to the requirements of Section 409A of the Code. Furthermore, with respect to Awards intended to qualify as “performance-based compensation” under Section 162(m) of the Code, such
adjustments shall be made only to the extent that the Committee determines that such adjustments may be made without causing the Company to be denied a tax deduction on account of Section 162(m) of the Code. Notwithstanding anything set forth
herein to the contrary, the Committee may, in its discretion, decline to adjust any Award made to a Participant, if it determines that such adjustment would violate applicable law or result in adverse tax consequences to the Participant or to the
Company. 
  

	7.	Awards Under The Plan 

 Awards under the
Plan may be granted as Options, SARs, Stock Awards or Cash Awards, as described below. Awards may be granted singly, in combination or in tandem as determined by the Committee, in its sole discretion. 

(a) Options. Options granted under the Plan shall be designated as Nonqualified Stock Options or ISOs. Options shall expire after
such period, not to exceed ten years, as may be determined by the Committee. If an Option is exercisable in installments, such installments or portions thereof that become exercisable shall remain exercisable until the Option expires or is otherwise
canceled pursuant to its terms. Except as otherwise provided in this Section 7(a), Options shall be subject to the terms, conditions, restrictions, and limitations determined by the Committee, in its sole discretion, from time to time.

 (i) ISOs. The terms and conditions of ISOs granted hereunder shall be subject to the provisions of Section 422 of
the Code and the terms, conditions, limitations and administrative procedures established by the Committee from time to time in accordance with the Plan. At the discretion of the Committee, ISOs may be granted only to an employee of the Company or a
Subsidiary. 
 (ii) Exercise Price. The Committee shall determine the exercise price per share for each Option, which
shall not be less than 100 percent of the Fair Market Value of the Common Stock for which the Option is exercisable at the time of grant. 
 (iii) Exercise of Options. Upon satisfaction of the applicable conditions relating to vesting and exercisability, as determined by the Committee, and upon provision for the payment in full of the
exercise price and applicable taxes due, the Participant shall be entitled to exercise the Option and receive the number of shares of Common Stock issuable in connection with the Option exercise. The shares of Common Stock issued in connection with
the Option exercise may be subject to such conditions and restrictions as the Committee may determine, from time to time. The exercise price of an Option and applicable withholding taxes relating to

  
 -8-

 
an Option exercise may be paid by methods permitted by the Committee from time to time including, but not limited to, (l) a cash payment; (2) tendering (either actually or by
attestation) shares of Common Stock owned by the Participant (for any minimum period of time that the Committee, in its discretion, may specify), valued at the Fair Market Value at the time of exercise; (3) arranging to have the appropriate
number of shares of Common Stock issuable upon the exercise of an Option withheld or sold; or (4) any combination of the above. Additionally, the Committee may provide that an Option may be “net exercised,” meaning that upon the
exercise of an Option or any portion thereof, the Company shall deliver the greatest number of whole shares of Common Stock having a Fair Market Value on the date of exercise not in excess of the difference between (x) the aggregate Fair Market
Value of the shares of Common Stock subject to the Option (or the portion of such Option then being exercised) and (y) the aggregate exercise price for all such shares of Common Stock under the Option (or the portion thereof then being
exercised) plus (to the extent it would not give rise to adverse accounting consequences pursuant to applicable accounting principles) the amount of withholding tax due upon exercise, with any fractional share that would result from such equation to
be payable in cash, to the extent practicable, or canceled. 
 (iv) ISO Grants to 10 percent Stockholders.
Notwithstanding anything to the contrary in this Section 7(a), if an ISO is granted to a Participant who owns stock representing more than ten percent of the voting power of all classes of stock of the Company, its “parent
corporation” (as such term is defined in Section 424 (e) of the Code) or a Subsidiary, the term of the Option shall not exceed five years from the time of grant of such Option and the exercise price shall be at least 110 percent of
the Fair Market Value (at the time of grant) of the Common Stock subject to the Option. 
 (v) $100,000 Per Year
Limitation/or ISOs. To the extent the aggregate Fair Market Value (determined at the time of grant) of the Common Stock for which ISOs are exercisable for the first time by any Participant during any calendar year (under all plans of the
Company) exceeds $100,000, such excess ISOs shall be treated as Nonqualified Stock Options. 
 (vi) Disqualifying
Dispositions. Each Participant awarded an ISO under the Plan shall notify the Company in writing immediately after the date he or she makes a “disqualifying disposition” of any shares of Common Stock acquired pursuant to the exercise
of such ISO. A “disqualifying disposition” is any disposition (including any sale) of such Common Stock before the later of (i) two years after the time of grant of the ISO and (ii) one year after the date the Participant
acquired the shares of Common Stock by exercising the ISO. The Company may, if determined by the Committee and in accordance with procedures established by it, retain possession of any shares of Common Stock acquired pursuant to the exercise of an
ISO as agent for the applicable Participant until the end of the period described in the preceding sentence, subject to complying with any instructions from such Participant as to the sale of such Stock. 

(b) Stock Appreciation Rights. A SAR represents the right to receive a payment in cash, Common Stock, or a combination thereof, in
an amount equal to the excess of the Fair Market Value of a specified number of shares of Common Stock at the time the SAR is exercised over the exercise price of such SAR, which shall be no less than 100 percent of the Fair Market Value of the same
number of shares at the time the SAR was granted. Except as otherwise provided in this Section 7(b), SARs shall be subject to the terms, conditions, restrictions and limitations determined by the Committee, in its sole discretion, from time to
time. A SAR may only be granted to an Eligible Recipient to whom an Option could be granted under the Plan. 

  
 -9-

 (c) Stock Awards. 

(i) Form of Awards. The Committee may grant Awards that are payable in shares of Common Stock or denominated in units equivalent
in value to shares of Common Stock or are otherwise based on or related to shares of Common Stock (“Stock Awards”), including, but not limited to, Restricted Stock, Deferred Stock and Stock Units. Stock Awards shall be subject to
such terms, conditions (including, without limitation, service-based and performance-based vesting conditions), restrictions and limitations as the Committee may determine to be applicable to such Stock Awards, in its sole discretion, from time to
time. 
 (ii) Stock Payment. If not prohibited by applicable law, the Committee may issue unrestricted shares of Common
Stock, alone or in tandem with other Awards, in such amounts and subject to such terms and conditions as the Committee shall from time to time in its sole discretion determine; provided, however, that to the extent Section 409A of the Code is
applicable to the grant of unrestricted shares of Common Stock that are issued in tandem with another Award, then such tandem Awards shall conform to the requirements of Section 409A of the Code. A Stock Payment may be granted as, or in payment
of, a bonus (including, without limitation, any compensation that is intended to qualify as “performance-based compensation” for purposes of Section 162(m) of the Code), or to provide incentives or recognize special achievements or
contributions. 
 (iii) Restricted Stock. Restricted Stock shall be subject to the terms, conditions, restrictions, and
limitations determined by the Committee, in its sole discretion, from time to time. The number of shares of Restricted Stock allocable to an Award under the Plan shall be determined by the Committee in its sole discretion. 

(iv) Deferred Stock. Subject to Section 409A of the Code to the extent applicable, Deferred Stock shall be subject to the
terms, conditions, restrictions and limitations determined by the Committee, in its sole discretion, from time to time. A Participant who receives an Award of Deferred Stock shall be entitled to receive the number of shares of Common Stock allocable
to his or her Award, as determined by the Committee in its sole discretion, from time to time, at the end of a specified deferral period determined by the Committee. Awards of Deferred Stock represent only an unfunded, unsecured promise to deliver
shares in the future and do not give Participants any greater rights than those of an unsecured general creditor of the Company. 
 (v) Stock Units. A Stock Unit is an Award denominated in shares of Common Stock that may be settled either in shares of Common Stock or in cash, in the discretion of the Committee, and, subject to
Section 409A of the Code to the extent applicable, shall be subject to such other terms, conditions, restrictions and limitations determined by the Committee from time to time in its sole discretion. 

(d) Cash Awards. The Committee may grant Awards that are payable to Participants in cash, as deemed by the Committee to be
consistent with the purposes of the Plan, and, except 

  
 -10-

 
as otherwise provided in this Section 7(d), such Cash Awards shall be subject to the terms, conditions, restrictions, and limitations determined by the Committee, in its sole discretion,
from time to time. Awards granted pursuant to this Section 7(d) may be granted with value and payment contingent upon the achievement of Performance Criteria, and, if so granted, such criteria shall relate to periods of performance equal to or
exceeding one calendar year. The maximum amount that any Covered Employee may receive with respect to a Cash Award granted pursuant to this Section 7(d) in respect of any annual performance period is $2,500,000 and for any other performance
period in excess of one year, such amount multiplied by a fraction, the numerator of which is the number of months in the performance period and the denominator of which is twelve. Payments earned hereunder may be decreased or, with respect to any
Participant who is not a Covered Employee, increased in the sole discretion of the Committee based on such factors as it deems appropriate. No payment shall be made to a Covered Employee under this Section 7(d) prior to the certification by the
Committee that the Performance Criteria have been attained. The Committee may establish such other rules applicable to Cash Awards to the extent not inconsistent with Section 162(m) of the Code. 

 

	8.	Forfeiture Provisions Following a Termination of Employment or Service as a Consultant or Independent Contractor 

Except where prohibited by applicable law or where otherwise determined by the Committee, in any instance where the rights of a Participant with respect
to an Award extend past the date of termination of a Participant’s service to the Company or its Subsidiaries, all of such rights shall terminate and be forfeited, if, in the determination of the Committee, the Participant, at any time
subsequent to his or her termination of service, engages, directly or indirectly, either personally or as an employee, agent, partner, stockholder, officer or director of, or consultant to, any Person engaged in any business in which the Company or
its Subsidiaries is engaged, in conduct that breaches any obligation or duty of such Participant to the Company or a Subsidiary or that is in material competition with the Company or a Subsidiary or is materially injurious to the Company or a
Subsidiary, monetarily or otherwise, which conduct shall include, but not be limited to, (i) disclosing or misusing any confidential information pertaining to the Company or a Subsidiary; (ii) any attempt, directly or indirectly, to induce
any employee or agent of the Company or any Subsidiary to be employed or perform services elsewhere; (iii) any attempt by a Participant, directly or indirectly, to solicit the trade of any customer or supplier or prospective customer or
supplier of the Company or any Subsidiary; or (iv) disparaging the Company, any Subsidiary or any of their respective officers or directors. The Committee shall make the determination of whether any conduct, action or failure to act falls
within the scope of activities contemplated by this Section 8, in its sole discretion. For purposes of this Section 8, a Participant shall not be deemed to be a stockholder of a competing entity if the Participant’s record and
beneficial ownership amount to not more than one percent of the outstanding capital stock of any company subject to the periodic and other reporting requirements of the Exchange Act. 

 

	9.	Dividends and Dividend Equivalents 

 The
Committee may, in its sole discretion, provide that Stock Awards shall earn dividends or dividend equivalents, as applicable. Such dividends or dividend equivalents may be paid currently or may be credited to an account maintained on the books of
the Company. Any 

  
 -11-

 
payment or crediting of dividends or dividend equivalents will be subject to such terms, conditions, restrictions and limitations as the Committee may establish, from time to time, in its sole
discretion, including, without limitation, reinvestment in additional shares of Common Stock or common share equivalents; provided, however, if the payment or crediting of dividends or dividend equivalents is in respect of a Stock Award that is
subject to Section 409A of the Code, then the payment or crediting of such dividends or dividend equivalents shall conform to the requirements of Section 409A of the Code and such requirements shall be specified in writing. Notwithstanding
the foregoing, dividends or dividend equivalents may not be paid or accrue with respect to any Stock Award subject to the achievement of Performance Criteria, unless and until the relevant Performance Criteria have been satisfied, and then only to
the extent determined by the Committee, as specified in the Award Agreement. 
  

	10.	Voting 

 The Committee shall determine
whether a Participant shall have the right to direct the vote of shares of Common Stock allocated to a Stock Award. If the Committee determines that a Stock Award shall carry voting rights, the shares allocated to such Stock Award shall be voted by
such Person as the Committee may designate (the “Plan Administrator”) in accordance with instructions received from Participants (unless to do so would constitute a violation of fiduciary duties or any applicable exchange rules). In
such cases, shares subject to Awards as to which no instructions are received shall be voted by the Plan Administrator proportionately in accordance with instructions received with respect to all other Awards (including, for these purposes,
outstanding awards granted under any other plan of the Company) that are eligible to vote (unless to do so would constitute a violation of fiduciary duties or any applicable exchange rules). 

 

	11.	Payments and Deferrals 

(a) Payment of vested Awards may be in the form of cash, Common Stock or combinations thereof as the Committee shall determine, subject to
such terms, conditions, restrictions and limitations as it may impose. The Committee may (i) postpone the exercise of Options or SARs (but not beyond their expiration dates), (ii) require or permit Participants to elect to defer the
receipt or issuance of shares of Common Stock pursuant to Awards or the settlement of Awards in cash (including Cash Awards) under such rules and procedures as it may establish, in its discretion, from time to time, (iii) provide for deferred
settlements of Awards including the payment or crediting of earnings on deferred amounts, or the payment or crediting of dividend equivalents where the deferred amounts are denominated in common share equivalents, and (iv) stipulate in any
Award Agreement, either at the time of grant or by subsequent amendment, that a payment or portion of a payment of an Award be delayed in the event that Section 162(m) of the Code (or any successor or similar provision of the Code) would
disallow a tax deduction by the Company for all or a portion of such payment; provided, that the period of any such delay in payment shall be until the payment, or portion thereof, is tax deductible, or such earlier date as the Committee shall
determine in its sole discretion. Notwithstanding the foregoing, with respect to any Award subject to Section 409A of the Code, the Committee shall not take any action described in the preceding sentence unless it determines that such action
will not result in any adverse tax consequences under Section 409A of the Code. 

  
 -12-

 (b) If, pursuant to any Award granted under the Plan, a Participant is entitled to receive a
payment on a specified date, such payment shall be deemed made as of such specified date if it is made (i) not earlier than 30 days before such specified date and (ii) not later than December 31 of the year in which such specified
date occurs or, if later, the fifteenth day of the third month following such specified date, in each case provided that, to the extent necessary to avoid the imposition of additional taxes or penalties under Section 409A of the Code, the
Participant shall not be permitted, directly or indirectly, to designate the taxable year in which such payment is made. 
 (c)
Notwithstanding the foregoing, to the extent necessary to avoid the imposition of additional taxes or penalties under Section 409A of the Code, if a Participant is a Specified Employee at the time of his or her Separation from Service, any
payment(s) with respect to any Award subject to Section 409A of the Code to which such Participant would otherwise be entitled by reason of such Separation from Service shall be made on the date that is six months after the Participant’s
Separation from Service (or, if earlier, the date of the Participant’s death). 
 (d) If, pursuant to any Award granted
under the Plan, a Participant is entitled to a series of installment payments, such Participant’s right to the series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment.
For purposes of the preceding sentence, the term “series of installment payments” has the same meaning as provided in Section 1.409A-2(b)(2)(iii) of the Treasury Regulations. 

 

	12.	Nontransferability 

 Awards granted under
the Plan, and during any period of restriction on transferability, shares of Common Stock issued in connection with the exercise of an Option or a SAR, may not be sold, pledged, hypothecated, assigned, margined or otherwise transferred in any manner
other than by will or the laws of descent and distribution, unless and until the shares underlying such Award have been issued, and all restrictions applicable to such shares have lapsed or have been waived by the Committee. No Award or interest or
right therein shall be subject to the debts, contracts or engagements of a Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means
whether such disposition be voluntary or involuntary or by operation of law, by judgment, lien, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy and divorce), and any attempted disposition thereof shall
be null and void, of no effect, and not binding on the Company in any way. Notwithstanding the foregoing, the Committee may, in its sole discretion, permit (on such terms, conditions and limitations as it may establish) Nonqualified Stock Options
and/or shares issued in connection with an Option or a SAR exercise that are subject to restrictions on transferability, to be transferred to a member of a Participant’s immediate family or to a trust or similar vehicle for the benefit of a
Participant’s immediate family members. During the lifetime of a Participant, all rights with respect to Awards shall be exercisable only by such Participant or, if applicable pursuant to the preceding sentence, a permitted transferee.

  
 -13-

	13.	Change of Control 

 (a)
Unless otherwise determined in an Award Agreement, in the event of a Change of Control: 
 (i) With respect to each outstanding
Award that is assumed or substituted in connection with a Change of Control, in the event of a termination of a Participant’s employment or service without Cause during the 24-month period following such Change of Control, (i) such Award
shall become fully vested and exercisable, (ii) the restrictions, payment conditions, and forfeiture conditions applicable to any such Award granted shall lapse, and (iii) and any performance conditions imposed with respect to Awards shall
be deemed to be achieved at target performance levels. 
 (ii) With respect to each outstanding Award that is not assumed or
substituted in connection with a Change of Control, immediately upon the occurrence of the Change of Control, (x) such Award shall become fully vested and exercisable, (y) the restrictions, payment conditions, and forfeiture conditions
applicable to any such Award granted shall lapse, and (z) any performance conditions imposed with respect to Awards shall be deemed to be achieved at target performance levels. 

(iii) For purposes of this Section 13, an Award shall be considered assumed or substituted for if, following the Change of Control,
the Award remains subject to the same terms and conditions that were applicable to the Award immediately prior to the Change of Control except that, if the Award related to shares of Common Stock, the Award instead confers the right to receive
common stock of the acquiring entity. 
 (iv) Notwithstanding any other provision of the Plan, in the event of a Change of
Control, except as would otherwise result in adverse tax consequences under Section 409A of the Code, the Committee may, in its discretion, provide that each Award shall, immediately upon the occurrence of a Change of Control, be cancelled in
exchange for a payment in cash or securities in an amount equal to (y) the excess of the consideration paid per share of Common Stock in the Change of Control over the exercise or purchase price (if any) per share of Common Stock subject to the
Award multiplied by (z) the number of shares of Common Stock granted under the Award. 
 (b) A “Change of
Control” shall be deemed to occur if and when the first of the following occurs: 
 (i) any Person, other than SABA, is or
becomes a beneficial owner (as such term is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing one-third or more of the combined voting power of the Company’s then outstanding
securities (other than through acquisitions from SABA or the Company); 
 (ii) any plan or proposal for the dissolution or
liquidation of the Company is adopted by the stockholders of the Company; 
 (iii) individuals who, as of the Effective Date,
constituted the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, 

  
 -14-

 
however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least
a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding for this purpose any such individual whose initial assumption of office occurs as a
result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person
other than the Board; 
 (iv) all or substantially all of the assets of the Company are sold, transferred or distributed; or

 (v) there occurs a reorganization, merger, consolidation or other corporate transaction involving the Company (a
“Transaction”), in each case, with respect to which the stockholders of the Company immediately prior to such Transaction do not, immediately after the Transaction, own more than 50 percent of the combined voting power of the
Company or other entity resulting from such Transaction (disregarding, in each case, SABA) in substantially the same respective proportions as such stockholders’ ownership of the voting power of the Company immediately before such Transaction;
provided, however, that a Transaction shall not constitute a Change in Control if the Transaction occurs at such time that SABA owns more than 50 percent of the combined voting power of the Company. 

(c) Notwithstanding the foregoing, no event shall constitute a Change of Control if, immediately following such event, (i) SABA
beneficially owns, directly or indirectly, 33 1/3 percent or more of the combined voting power of the Company’s then outstanding securities (or, in the case of clause 13(b)(v) above, voting securities of the entity resulting from the applicable
Transaction entitled to vote generally in the election of directors), and (y) no person (other than the Company or any employee benefit plan (or related trust) of the Company or the resulting entity) owns, directly or indirectly, more of the
combined voting power of the Company’s then outstanding securities (or, in the case of clause 13(b)(v) above, voting securities of the entity resulting from the applicable Transaction entitled to vote generally in the election of directors)
than SABA. 
 (d) Notwithstanding the foregoing, for each Award that constitutes deferred compensation under Section 409A
of the Code, a Change of Control shall be deemed to have occurred under the Plan with respect to such Award only if a change in the ownership or effective control of the Company or a change in ownership of a substantial portion of the assets of the
Company shall also be deemed to have occurred under Section 409A of the Code. 
  

	14.	Award Agreements 

 Each Award under the
Plan shall be evidenced by an Award Agreement (as such may be amended from time to time) that sets forth the terms, conditions, restrictions and limitations applicable to the Award, including, but not limited to, the provisions governing vesting,
exercisability, payment, forfeiture, and termination of employment, all or some of which may be incorporated by reference into one or more other documents delivered or otherwise made available to a Participant in connection with an Award.

  
 -15-

	15.	Tax Withholding 

 Participants shall be
solely responsible for any applicable taxes (including, without limitation, income, payroll and excise taxes) and penalties, and any interest that accrues thereon, which they incur in connection with the receipt, vesting or exercise of an Award. The
Company and its Subsidiaries shall have the right to require payment of, or may deduct from any payment made under the Plan or otherwise to a Participant, or may permit shares to be tendered or sold, including shares of Common Stock delivered or
vested in connection with an Award, in an amount sufficient to cover withholding of any federal, state, local, foreign or other governmental taxes or charges required by law or such greater amount of withholding as the Committee shall determine from
time to time and to take such other action as may be necessary to satisfy any such withholding obligations. It shall be a condition to the obligation of the Company to issue Common Stock upon the exercise of an Option or a SAR that the Participant
pay to the Company, on demand, such amount as may be requested by the Company for the purpose of satisfying any tax withholding liability. If the amount is not paid, the Company may refuse to issue shares. 

 

	16.	Other Benefit and Compensation Programs 

Awards received by Participants under the Plan shall not be deemed a part of a Participant’s regular, recurring compensation for purposes of
calculating payments or benefits from any Company benefit plan or severance program unless specifically provided for under the plan or program. Unless specifically set forth in an Award Agreement, Awards under the Plan are not intended as payment
for compensation that otherwise would have been delivered in cash, and even if so intended, such Awards shall be subject to such vesting requirements and other terms, conditions and restrictions as may be provided in the Award Agreement. 

 

	17.	Unfunded Plan 

 The Plan is intended to
constitute an “unfunded” plan for incentive and deferred compensation. The Plan shall not establish any fiduciary relationship between the Company and any Participant or other Person. To the extent any Participant holds any rights by
virtue of an Award granted under the Plan, such rights shall constitute general unsecured liabilities of the Company and shall not confer upon any Participant or any other Person any right, title, or interest in any assets of the Company.

  

	18.	Rights as a Stockholder 

 Unless the
Committee determines otherwise, a Participant shall not have any rights as a stockholder with respect to shares of Common Stock covered by an Award until the date the Participant becomes the holder of record with respect to such shares. No
adjustment will be made for dividends or other rights for which the record date is prior to such date, except as provided in Section 9. 
  

	19.	Future Rights 

 No Eligible Recipient
shall have any claim or right to be granted an Award under the Plan. There shall be no obligation of uniformity of treatment of Eligible Recipients under the Plan. 

  
 -16-

 
Further, the Company and its Subsidiaries may adopt other compensation programs, plans or arrangements as deemed appropriate or necessary. The adoption of the Plan, or grant of an Award, shall
not confer upon any Eligible Recipient any right to continued employment or service in any particular position or at any particular rate of compensation, nor shall it interfere in any way with the right of the Company or a Subsidiary to terminate
the employment or service of Eligible Recipients at any time, free from any claim or liability under the Plan. 
  

	20.	Amendment and Termination 

(a) The Plan and any Award may be amended, suspended or terminated at any time by the Board, provided that no amendment shall be made
without stockholder approval if it would (i) materially increase the number of shares available under the Plan, (ii) materially expand the types of awards available under the Plan, (iii) materially expand the class of individuals
eligible to participate in the Plan, (iv) materially extend the term of the Plan, (v) materially change the method of determining the exercise price of an Award, (vi) delete or limit the prohibition against repricing contained in
Section 4(d), or (vii) otherwise require approval by the stockholders of the Company in order to comply with applicable law or the rules of the New York Stock Exchange (or, if the Common Stock is not traded on the New York Stock Exchange,
the principal national securities exchange upon which the Common Stock is traded or quoted). Notwithstanding the foregoing, with respect to Awards subject to Section 409A of the Code, any amendment, suspension or termination of the Plan or any
such Award shall conform to the requirements of Section 409A of the Code. Except as otherwise provided in Section 13(a)and Section 20(b) and (c), no termination, suspension or amendment of the Plan or any Award shall adversely affect
the right of any Participant with respect to any Award theretofore granted, as determined by the Committee, without such Participant’s written consent. 
 (b) The Committee may amend or modify the terms and conditions of an Award to the extent that the Committee determines, in its sole discretion, that the terms and conditions of the Award violate or may
violate Section 409A of the Code; provided, however, that (i) no such amendment or modification shall be made without the Participant’s written consent if such amendment or modification would violate the terms and conditions of a
Participant’s offer letter or employment agreement, and (ii) unless the Committee determines otherwise, any such amendment or modification of an Award made pursuant to this Section 20(b) shall maintain, to the maximum extent
practicable, the original intent of the applicable Award provision without contravening the provisions of Section 409A of the Code. The amendment or modification of any Award pursuant to this Section 20(b) shall be at the Committee’s
sole discretion and the Committee shall not be obligated to amend or modify any Award or the Plan, nor shall the Company be liable for any adverse tax or other consequences to a Participant resulting from such amendments or modifications or the
Committee’s failure to make any such amendments or modifications for purposes of complying with Section 409A of the Code or for any other purpose. To the extent the Committee amends or modifies an Award pursuant to this Section 20(b),
the Participant shall receive notification of any such changes to his or her Award and, unless the Committee determines otherwise, the changes described in such notification shall be deemed to amend the terms and conditions of the applicable Award
and Award Agreement. 

  
 -17-

	21.	Reimbursement or Cancellation of Certain Awards 

 In the event that the Board determines that an Award that was granted, vested or paid based on the achievement of Performance Criteria or other performance metrics would not have been granted, vested or
paid absent fraud or misconduct, or that would not have been granted, vested or paid absent events giving rise to a restatement of the Company’s financial statements, or a significant write-off not in the ordinary course affecting the
Company’s financial statements, the Board, in its discretion, shall take such action as it deems necessary or appropriate to address the fraud, misconduct, write-off or restatement. Such actions may include, without limitation and to the extent
permitted by applicable law, in appropriate cases, (i) requiring partial or full reimbursement of any Cash Award granted to the Participant, (ii) causing the partial or full cancellation of any Award granted to the Participant or
(iii) requiring partial or full repayment of the value of the Common Stock acquired on vesting or settlement of an Award, in each case as the Board determines to be in the best interests of the Company. 

 

	22.	Successors and Assigns 

 The Plan and any
applicable Award Agreement shall be binding on all successors and assigns of a Participant, including, without limitation, the estate of such Participant and the executor, administrator or trustee of such estate, or any receiver or trustee in
bankruptcy or representative of the Participant’s creditors. 
  

	23.	Governing Law 

 The Plan and all
agreements entered into under the Plan shall be construed in accordance with and governed by the laws of the State of Delaware. 
  

	24.	Section 409A of the Code 

 The intent
of the parties is that payments and benefits under the Plan comply with Section 409A of the Code to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and be administered to be in
compliance therewith. 
  

	25.	No Liability With Respect to Tax Qualification or Adverse Tax Treatment 

 Notwithstanding any provision of the Plan to the contrary, in no event shall the Company or any Affiliate be liable to a Participant on account of an Award’s failure to (i) qualify for favorable
U.S. or foreign tax treatment or (ii) avoid adverse tax treatment under U.S. or foreign law, including, without limitation, Section 409A of the Code. 

  
 -18-

 FORM OF 
 TAYLOR & MARTIN GROUP, INC. 
 RESTRICTED STOCK AWARD AGREEMENT

 Taylor & Martin Group, Inc., a Delaware corporation (the “Company”), hereby grants to
                     (the “Participant”), the restricted shares (“Restricted Shares”) of common stock, par value $0.00001 per
share of the Company (“Common Stock”) referred to in Section 1 below pursuant to the Taylor & Martin Group, Inc. 2011 Omnibus Incentive Plan (the “Plan”). The terms, conditions and restrictions applicable to the
Restricted Shares are contained in the Plan and in this Restricted Stock Award Agreement (the “Agreement”). Capitalized terms not defined herein shall have the meaning assigned to such terms in the Plan. 

1. Grant of Restricted Shares. 
  

			
	Grant Date:	  	                 , 20    
	Number of Shares:	  	[# SHARES]
	Forfeiture Lapse Dates (20% of the Restricted Shares shall be released from risk of forfeiture on each specified date, provided the performance target, if applicable, for that date
set forth in Section 14 below has been met):	  	  
  
 First Anniversary of Grant Date
 Second Anniversary of Grant Date

Third Anniversary of Grant Date
 Fourth
Anniversary of Grant Date
 Fifth Anniversary of Grant Date

 2. Termination of Employment. Notwithstanding anything to the contrary herein, upon a termination of the
Participant’s employment, the Restricted Shares shall be treated as follows (unless the terms of any Employment Agreement between the Company or one of its Affiliates and the Participant (an “Employment Agreement”) expressly provide
otherwise, in which event the terms of the Employment Agreement shall control the results of such termination): 
 (a)
Voluntary Resignation; Termination for Cause. If the Participant voluntarily terminates employment with the Company other than for Good Reason (as hereinafter defined) or if the Company terminates the Participant’s employment for Cause,
the Restricted Shares that are still subject to risk of forfeiture on the date the Participant’s employment is so terminated will be forfeited, the forfeited portion of the Restricted Shares (if any) will be canceled and the Participant shall
have no further rights of any kind with respect to any forfeited Restricted Shares. Notwithstanding anything in the Plan to the contrary, for purposes of this Agreement, “Cause” shall mean: 

(i) the Participant’s willful misconduct or gross negligence that causes material harm to the Company; 

(ii) a material violation of the Company’s written corporate governance guidelines, policies or procedures as specified in the
Company’s Employee Handbook; 

 (iii) the Participant’s habitual substance abuse; 

(iv) the Participant’s willful and continued failure (other than as a result of physical or mental incapacity) to perform the duties
of the Participant’s position or to follow the legal direction of the Committee which is not cured within 30 days following written notice from the Committee specifying such failure; 

(v) the Participant’s being convicted of, or pleading guilty or nolo contendere to a felony or a crime involving moral turpitude,
dishonesty or breach of trust; 
 (vi) the Participant’s willful theft, embezzlement or act of comparable dishonesty
against the Company or any Affiliate; or 
 (vii) a material breach by the Participant of the provisions of this
Section (2(a), which breach is not (if curable) cured by the Participant within 30 days following his receipt of written notice thereof. 

For purposes of this definition, no act or failure to act by the Participant shall be considered “willful” unless it is done, or omitted to be
done, in bad faith and without reasonable belief that the Participant’s action or omission was in the best interests of the Company or an Affiliate. A termination of employment of the Participant shall not be deemed to be for Cause unless and
until there shall have been delivered to the Participant a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the entire membership of the Committee at a meeting of the Committee called and held for such purpose
(at which the Participant has been given the opportunity to appear with counsel on reasonable written notice specifying the alleged Cause event), finding that, in the good faith opinion of the Committee, the Participant is guilty of the conduct
described in one or more of the clauses of this paragraph (a), and specifying the particulars thereof in detail. 
 (b) Death
or Involuntary Termination Other than for Cause. If the Participant’s employment is terminated by the Company for any reason other than Cause (other than following the Participant’s disability, as described below) or by the Participant
for Good Reason, or upon the Participant’s death, the forfeiture provisions applicable to the Restricted Shares (if any) will lapse as of the termination date. The Participant’s employment may be terminated by the Participant for
“Good Reason” if (x) an event or circumstance set forth in clauses (i) – (v) of this Section 2(b) below shall have occurred and the Participant provides the Company with written notice thereof within 90 days after
the occurrence or existence of such event or circumstance, which notice shall specifically identify the event or circumstance that the Participant believes constitutes Good Reason, (y) the Company fails to correct the circumstance or event so
identified within 30 days after the receipt of such notice (the “Cure Period”), and (z) the Participant resigns within 30 days after the end of the Cure Period. For purposes of this Agreement, “Good Reason” shall mean, in
the absence of the Participant’s written consent, the occurrence of any of the following: 
 (i) a material diminution by
the Company in the Participant’s annual base salary or a material diminution in the Participant’s target bonus opportunity as a percentage of the Participant’s annual base salary; 

  
 -3-

 (ii) a material diminution in the Participant’s authority, duties or responsibilities;

 (iii) a material diminution in the Participant’s reporting relationship; 

(iv) any requirement that the Participant’s principal business location be at any office or location more than 25 miles from the
Participant’s principal business location as of the date immediately prior to such relocation (other than to an office or location closer to the Participant’s home residence); or 

(v) any material breach of this Agreement by the Company. 
 (c) Disability. The Restricted Shares will continue to be subject to risk of forfeiture during the first 12 months of the Participant’s approved disability leave pursuant to the Company
disability policy applicable to the Participant (the “Disability Policy”). If the Participant remains on an approved disability leave for more than one year pursuant to the Disability Policy, the risk of forfeiture provisions applicable to
the Restricted Shares (if any) will lapse as of the first anniversary of the commencement of such approved disability leave. 
 3.
Stockholder Rights. The Participant will have all of the rights of a holder of shares with respect to the Restricted Shares (until and unless the Restricted Shares are forfeited), including, without limitation, the right to vote such shares
and the right to receive all dividends or other distributions with respect to such shares, both prior to and after the lapse and removal of the forfeiture provisions set forth herein, and, if shares are ultimately forfeited, prior to such
forfeiture. 
 4. Consent to Electronic Delivery. In lieu of receiving documents in paper format, by receipt of the Restricted Shares,
the Participant consents, to the fullest extent permitted by law, to electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications
and agreements and all other forms or communications) in connection with the Restricted Shares. Electronic delivery of a document to the Participant may be via the Company’s e-mail system or by reference to a location on an Internet site to
which the Participant has access. 
 5. Tax Withholding. The Participant shall be solely responsible for any applicable taxes (including,
without limitation, income, payroll and excise taxes) and penalties, and any interest that accrues thereon, incurred in connection with the Restricted Shares, including the payment of any dividends with respect thereto. Upon the lapse of the
forfeiture provisions applicable to the Restricted Shares, the Company shall have the right to require payment of, or may deduct or sell a number of shares sufficient to cover, withholding of any applicable federal, state, local, foreign or other
governmental taxes or charges required by law or such greater amount of withholding as the Committee shall determine from time to time and to take such other action as may be necessary to satisfy any such withholding obligations. 

6. Entire Agreement. The Agreement and the Plan constitute the entire understanding between the Company and the Participant regarding the
Restricted Shares and supersede all previous written, oral, or implied understandings between the parties hereto about the subject matter hereof; provided that in the event that the terms of an Employment Agreement are inconsistent with the terms of
the Agreement or the Plan, the terms of the Employment Agreement shall control. 

  
 -4-

 7. No Right to Employment. Nothing contained herein, in the Plan, or in any prospectus shall confer
upon the Participant any rights to continued employment or employment in any particular position, at any specific rate of compensation, or for any particular period of time. 
 8. Arbitration. Any disputes related to the Restricted Shares shall be resolved by arbitration in accordance with the Company’s arbitration policies. In the absence of an effective arbitration
policy, the Participant acknowledges and agrees that any dispute related to the Restricted Shares shall be submitted to arbitration in accordance with the Commercial Rules of the American Arbitration Association, if so elected by the Company in its
sole discretion. 
 9. Conflict. In the event of a conflict between the Agreement and the Plan, the Plan shall control. In the event of a
conflict between the Agreement or the Plan, on the one hand, and any Employment Agreement, on the other hand, the terms of the Employment Agreement shall control. 
 10. Governing Law. The Agreement shall be construed in accordance with and governed by the laws of the State of Delaware, without regard to the application of any choice-of-law rules that would
result in the application of another state’s laws. The Participant and the Company consent to the exclusive jurisdiction and venue in the federal and state courts of the State of Texas sitting in Harris County for the resolution of all disputes
arising under, or relating to, this Agreement. 
 11. Internal Revenue Code Section 409A. The intent of the parties is that the
Restricted Shares granted hereunder be exempt from Section 409A of the Code, and, to the maximum extent permitted, the Agreement and the Plan shall be interpreted and be administered accordingly. 

12. Successors and Assigns. The Agreement shall be binding on all successors and assigns of the Participant, including, without limitation, the
estate of the Participant and the executor, administrator or trustee of such estate, or any receiver or trustee in bankruptcy or representative of the Participant’s creditors. 
 13. Restriction on Disposition. By receipt of the Restricted Shares, the Participant acknowledges and agrees that the Participant will not offer, sell, contract to sell, hedge, pledge or otherwise
dispose of, or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition of (whether by actual disposition or effective economic disposition due to cash settlement or otherwise), directly or
indirectly, any of these Restricted Shares, or publicly announce an intention to effect any such transaction, for a period of one year from the date of the final prospectus relating to Company initial public offering. In any event, the Participant
represents that all of the Restricted Shares are being acquired by the Participant solely for its own account, for investment purposes only, and with no present intention of distributing, selling or otherwise disposing of such securities in
connection with a distribution. The Participant acknowledges and agrees that it may not resale Restricted Shares without compliance with the requirements of the federal and applicable state securities laws. The

  
 -5-

 
Participant further acknowledges and agrees that any stock certificate evidencing issuance of the Restricted Shares shall bear an appropriate legend reflecting the foregoing restrictions. The
Participant further acknowledges and agrees that a breach of the restrictions set forth in this Section 13 shall result in the cancellation of the Restricted Shares. 
 14. Performance Target Levels. 
 Check One Box 

 

	 ̈	No performance target levels are applicable to this grant of Restricted Shares. 

 

	 ̈	The following performance target levels are applicable to this grant of Restricted Shares. 

 In addition to the continued employment of Participant by                      (the
“Employer”), the lapse of the forfeiture provisions referred to in Section 1 above shall also be conditioned upon the achievement by the Employer and its Subsidiaries, if any, of the following stipulated levels of earnings before
interest, taxes, depreciation and amortization (“EBITDA”) for the measurement periods noted below: 
  

											
	 Measurement Date
	  	 Measurement

Period
	  	Percentage of
Shares as to which
Forfeiture
Provisions 
Lapse	 	 	EBITDA Target 
Level1	 
	 First anniversary of Grant Date
	  	Preceding twelve calendar months	  	 	20	% 	 	 	    % of Base EBITDA	2 
	 Second anniversary of Grant Date
	  	Preceding twelve calendar months	  	 	20	% 	 	 	    % of Base EBITDA	  
	 Third anniversary of Grant Date
	  	Preceding twelve calendar months	  	 	20	% 	 	 	    % of Base EBITDA	  
	 Fourth anniversary of Grant Date
	  	Preceding twelve calendar months	  	 	20	% 	 	 	    % of Base EBITDA	  
	 Fifth anniversary of Grant Date
	  	Preceding twelve calendar months	  	 	20	% 	 	 	    % of Base EBITDA	  

  

	1 	 In computing EBITDA for periods subsequent to                  ,
20    , the Company shall use actual revenues for the relevant measurement period and the expenses used in determining Base EBITDA. 

	2 	 Base EBITDA will be the combined EBITDA of the Employer and its Subsidiaries, if any, for the year ending
                 , 20    , computed by combining the components of EBITDA reflected in the combined financial statements of the foregoing entities
for such period audited and reported on by KPMG, LLP, less any nonrecurring items. 

  
 -6-

 Shares that are not released from the forfeiture provision during any measurement period shall be carried
forward and may be released at a subsequent measurement date if the EBITDA target level for the applicable measurement period has been achieved. 
 [SIGNATURE PAGE TO FOLLOW] 

  
 -7-

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date first above written.

  

			
	TAYLOR & MARTIN GROUP, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	  

	[NAME OF PARTICIPANT]

 SIGNATURE PAGE TO TAYLOR &
MARTIN GROUP, INC. 
 RESTRICTED STOCK
AWARD AGREEMENTAsset Purchase Agreement

 Exhibit 10.1 
 ASSET PURCHASE AGREEMENT 
 This ASSET PURCHASE AGREEMENT (this
“Agreement”) is entered into as of October 2, 2012, by and among: Innovaro, Inc., a Delaware corporation (the “Seller”); Strategos, Inc., a Delaware corporation (the “Purchaser”) and certain
individuals listed on Exhibit A (collectively, the “Strategos Individuals” and together with the Seller and the Purchaser, the “Parties” or a “Party”). Certain capitalized terms used in this
Agreement are defined in Exhibit B. 
 RECITALS 

WHEREAS, the Strategos Individuals have agreed to end their employee relationship with the Seller in accordance with certain respective
Separation and Release Agreements by and between each Strategos Individual and the Seller (collectively, the “Separation Agreements”); 
 WHEREAS, the Seller has determined to divest its Strategos branded consulting business (the “Consulting Business”) and has agreed to sell it to the Strategos Individuals; 

WHEREAS, the Strategos Individuals have formed Strategos, Inc., which intends on, among other things, acquiring assets and licensing
certain intellectual property used in the Consulting Business from the Seller; 
 AGREEMENT 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby
agree as follows: 
  

	1.	Sale of Assets; Related Transactions 

 1.1 Sale of Assets. The Seller shall cause to be sold, assigned, transferred, conveyed and delivered to the Purchaser good and valid title to certain properties, rights, interests and other
tangible and intangible assets of the Seller only as identified in this Agreement (the “Assets”) and the Licensing Agreement free of any Encumbrances, on the terms and subject to the conditions set forth in this Agreement:

 (a) subject to Section 7.3 of this Agreement, all accounts receivable of the Seller related to the Consulting
Business that are pending as of August 31, 2012 and identified in Schedule 1.1(a); 
 (b) all inventories and
work-in-progress of the Seller for the Consulting Business, and all rights to collect from customers (and to retain) all fees and other amounts payable, or that may become payable, to the Seller with respect to such services performed on behalf of
the Seller on or prior to the Closing Date; 
 (c) all equipment, materials, prototypes, tools, supplies, vehicles,
furniture, fixtures, improvements and other tangible assets of the Seller used in the Consulting Business (including the tangible assets identified in Schedule 1.1(c)) and any proceeds from the sale of such tangible assets during the months
of July and August, 2012; 

  
 1 

 (d) all advertising and promotional materials possessed by the Seller used in the
Consulting Business; 
 (e) the Intellectual Property and Intellectual Property Rights identified in Schedule 1.1(e),
(including the right to use the name “Strategos”) and variations thereof, and the goodwill of the Seller related thereto (the “Purchased IP”). Seller shall retain no rights to the Purchased IP; specifically, Seller,
its successors, and assigns, shall have no rights whatsoever to use the name “Strategos,” variations thereof, the Strategos Logo or variations thereos, the client and contact lists of the Consulting Business, or the web domain listed in
Schedule 1.1(e) for any purpose; 
 (f) all rights of the Seller under the Seller Contracts identified in Schedule
1.1(f)); 
 (g) all Governmental Authorizations held by the Seller (including the Governmental Authorizations
identified in Schedule 1.1(g)); 
 (h) all claims for past infringement or misappropriation of Intellectual
Property or Intellectual Property Rights identified in Schedule 1.1(e) against other Persons except those individuals executing Separation Agreements with Seller (regardless of whether or not such claims and causes of action have been asserted by
the Seller), and all rights of indemnity, warranty rights, rights of contribution, rights to refunds, rights of reimbursement and other rights of recovery possessed by the Seller (regardless of whether such rights are currently exercisable); and

 (i) all copies of the books, records, files and data of the Seller used in connection with the Consulting Business.

 1.2 Purchase Price. As consideration for the sale of the Assets to the Purchaser, at the Closing, the Purchaser shall
pay to the Seller, a total of $100,000 (the “Purchase Price”), which (i) those certain Strategos Individuals executing this Agreement acknowledge and agree that such amount has been deemed invested in the Purchaser by such
respective Strategos Individual, and (ii) each Party acknowledges and agrees will be deemed paid by the Purchaser in the form of an off set by the Seller against certain payments that it must make to the Strategos Individuals under their
respective Separation Agreements. 
 1.3 Excluded Assets. Notwithstanding anything to the contrary in this Agreement, the
Assets shall not include any assets unrelated to the Consulting Business, and including, without limitation, those assets listed on Exhibit C, nor any assets other than those described in Section 1.1, and the Excluded Assets shall
not be transferred to the Purchaser, but shall be retained by the Seller. 
 1.4 Sales Taxes. The Seller shall bear and
pay, and shall reimburse the Purchaser and the Purchaser’s affiliates for, any sales taxes, use taxes, transfer taxes, documentary charges, recording fees or similar taxes, charges, fees or expenses that may become payable in connection with
the sale of the Assets to the Purchaser or in connection with any of the other Transactions. 

  
 2 

 1.5 Closing. 

(a) The closing of the sale of the Assets to the Purchaser (the “Closing”) shall take place in Tampa, Florida at
10:00 a.m. on such date as the Purchaser may designate in a written notice delivered to the Seller; provided, however, that if any condition set forth in Section 4 has not been satisfied as of the date designated by the Purchaser.
For purposes of this Agreement “Closing Date” shall mean the time and date as of which the Closing actually takes place. 
 (b) At the Closing: 
 (i) the Seller shall execute and deliver to
the Purchaser such bills of sale, endorsements, assignments and other documents as may (in the reasonable judgment of the Purchaser or its counsel) be necessary or appropriate to assign, convey, transfer and deliver to the Purchaser good and valid
title to the Assets free of any Encumbrances; 
 (ii) the Purchaser and the Seller shall acknowledge the offset, in
which it is recognized that the Seller has received the Purchase Price as contemplated by Section 1.2(a); 
 (iii)
the Seller and the Purchaser shall execute and deliver to the other the License Agreement; and 
 (iv) the Strategos
Individuals and the Seller shall each execute and deliver to the other the respective Separation Agreements for each Strategos Individual. 
  

	2.	Representations and Warranties of the Seller. 

 The Seller represents and warrants, to the Purchaser, as follows: 
 2.1
Organization. The Seller (a) is a corporation duly incorporated, validly existing, and in good standing under its jurisdiction of incorporation; and (b) has all requisite corporate power and authority to execute, deliver, and perform
the Transactions contemplated hereby. 
 2.2 Authority and Enforceability. The execution, delivery, and performance by
the Seller of this Agreement and the consummation of the Transactions contemplated hereby are within the corporate power of the Seller and have been duly authorized by all necessary corporate actions on the part of the Seller. The execution of this
Agreement by the Seller constitutes the legal valid and binding obligations of the Seller, enforceable against the Seller in accordance with its terms, except as limited by bankruptcy, insolvency, or other laws of general application relating to or
affecting the enforcement of creditors’ rights generally and general principles of equity. 
 2.3 No Consents or
Approvals. No material consent, approval, authorization or Order of, or registration or filing with, or notice to, any court or Governmental Body having jurisdiction or regulatory authority over the Seller (or any of their properties) is
required for (a) the Seller’s execution and delivery of this Agreement (and each agreement executed and delivered by it in connection herewith) or (b) the consummation by the Seller of the Transactions

  
 3 

 
contemplated by this Agreement (and each agreement executed and delivered by it in connection herewith, including) and, to the extent any such material consent, approval, authorization, Order,
registration, filing or notice was required, it has been obtained, made or given (as applicable) and is still in full force and effect. 
 2.4 No Broker’s or Finder’s Fee. No Person or Entity acting on behalf of the Seller or any of their affiliates or under the authority of any of them is or will be entitled to any
brokers’ or finders’ fee or any other commission or similar fee, directly or indirectly, from the Purchaser or any of their affiliates in connection with any of the Transactions contemplated hereby. 

2.5 Title to the Assets. The Seller owns, and has good and valid title to the Assets; all rights of the Seller under Seller
Contracts. 
 2.6 Intellectual Property; Privacy. 

(a) Ownership Free and Clear. The Seller exclusively owns all right, title, and interest to the Purchased IP (other than
Intellectual Property Rights exclusively licensed to the Seller, as identified in Schedule 1.1(e)) free and clear of any Encumbrances (other than licenses and rights granted pursuant to the Contracts identified in Schedule 1.1(f))
except for Permitted Liens. Without limiting the generality of the foregoing: 
 (b) Perfection of Rights. All material
documents and instruments necessary to establish, perfect, and maintain the rights of the Seller in the Purchased IP have been validly executed, delivered, and filed in a timely manner with the appropriate Governmental Body. 

(i) Employees and Contractors. Each Person who is or was an employee or contractor of the Seller and who is or was involved in
the creation or development of any Purchased IP has signed a valid, enforceable agreement containing an assignment of Intellectual Property Rights pertaining to such Purchased IP to the Seller and confidentiality provisions protecting the Purchased
IP. No current or former shareholder, officer, director, or employee of the Seller has any claim, right (whether or not currently exercisable), or interest to or in any Purchased IP. No employee of the Seller is in breach of any Contract with any
former employer or other Person concerning any Purchased IP due to his activities as an employee of the Seller. 
 (ii)
Government Rights. No funding, facilities, or personnel of any Governmental Body or any public or private university, college, or other educational or research institution were used, directly or indirectly, to develop or create, in whole or in
part, any Seller IP. 
 (iii) Protection of Proprietary Information. The Seller has taken all reasonable steps to
maintain the confidentiality of and otherwise protect and enforce their rights in all proprietary information pertaining to the Purchased IP. Without limiting the generality of the foregoing, no portion of the source code for any Purchased IP has
been disclosed or licensed to any escrow agent or other Person. 

  
 4 

 (c) Valid and Enforceable. All Purchased IP is valid, subsisting, and enforceable.
Without limiting the generality of the foregoing: 
 (i) Misuse and Inequitable Conduct. The Seller has not engaged in
patent or copyright misuse or any fraud or inequitable conduct in connection with any Purchased IP that is Registered IP. 

(ii) Trademarks. No trademark or trade name owned, used, or applied for by the Seller that is Purchased IP conflicts or
interferes with any trademark or trade name owned, used, or applied for by any other Person. No event or circumstance (including a failure to exercise adequate quality controls and an assignment in gross without the accompanying goodwill) has
occurred or exists that has resulted in, or could reasonably be expected to result in, the abandonment of any trademark (whether registered or unregistered) owned, used, or applied for by the Seller that is Purchased IP. 

(iii) Legal Requirements and Deadlines. Each item of Purchased IP that is Registered IP is and at all times has been in
compliance with all legal requirements and all filings, payments, and other actions required to be made or taken to maintain such item of Purchased IP in full force and effect have been made by the applicable deadline. No application for a patent or
a copyright, mask work, or trademark registration or any other type of Registered IP that is Purchased IP filed by or on behalf of the Seller has been abandoned, allowed to lapse, or rejected. Schedule 2.6(b)(iii) accurately identifies and
describes as of the date of this Agreement each action, filing, and payment that must be taken or made on or before the date that is 120 days after the date of this Agreement in order to maintain such item of Purchased IP in full force and effect.

 (iv) Interference Proceedings and Similar Claims. No interference, opposition, reissue, reexamination, or other
Proceeding is has been pending or, to the best of the Seller’s Knowledge, threatened, in which the scope, validity, or enforceability of any Purchased IP is being, has been, or could reasonably be expected to be contested or challenged. To the
best of the Seller’s Knowledge, there is no basis for a claim that any Purchased IP is invalid or unenforceable. 
 (d)
Third-Party Infringement of Company IP. To the best of the Seller’s Knowledge, no Person has infringed, misappropriated, or otherwise violated, and no Person is currently infringing, misappropriating, or otherwise violating, any Purchased
IP. Schedule 2.6(c) accurately identifies (and the Seller has provided to the Purchaser a complete and accurate copy of) each letter or other written or electronic communication or correspondence that has been sent or otherwise delivered by
or to the Seller or any representative of the Seller regarding any actual, alleged, or suspected infringement or misappropriation of any Purchased IP, and provides a brief description of the current status of the matter referred to in such letter,
communication, or correspondence. 
 (e) Effects of This Transaction. Neither the execution, delivery, or performance of
this Agreement (or any of the ancillary agreements) nor the consummation of any of the Transactions contemplated by this Agreement (or any of the ancillary agreements) will, with or without notice or lapse of time, result in, or give any other
Person the right or option 

  
 5 

 
to cause or declare, (a) a loss of, or Encumbrance on, any Purchased IP; (b) a breach of or default under any Seller Purchased IP Contract; (c) the release, disclosure, or delivery
of any Purchased IP by or to any escrow agent or other Person; or (d) the grant, assignment, or transfer to any other Person of any license or other right or interest under, to, or in any Purchased IP. 

(f) Infringement Claims. No infringement, misappropriation, or similar claim or Proceeding is pending or, to the best of the
Seller’s Knowledge, threatened against the Seller or against any other Person who is or may be entitled to be indemnified, defended, held harmless, or reimbursed by the Seller with respect to such claim or Proceeding, in each case with respect
to the Purchased IP. The Seller has never received any notice or other communication (in writing or otherwise) suggesting or offering that the Purchased IP infringes on a license to any Intellectual Property Right of another Person. 

2.7 Contracts. Schedule 1.1(f) identifies and provides an accurate and complete description of each Seller Contract. The
Seller has delivered to the Purchaser accurate and complete copies of all Contracts identified in Schedule 1.1(f), including all amendments thereto. Each Seller Contract is valid and in full force and effect. 

2.8 No Additional Representations. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN SECTION 2 OF THIS AGREEMENT, THE SELLER EXPRESSLY
DISCLAIMS ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE, EXPRESS OR IMPLIED, AS TO THE CONDITION, VALUE OR QUALITY OF THE CONSULTING BUSINESS OR THE ASSETS. 
  

	3.	Representations and Warranties of the Purchaser. 

 The Purchaser, jointly and severally, represents and warrants, to the Seller, as follows: 
 3.1 Organization. The Purchaser (a) is a duly organized corporation, validly existing, and in good standing under the laws of its jurisdiction of organization; and (b) has all requisite
corporate power and authority to execute, deliver, and perform the Transactions contemplated hereby. 
 3.2 Authority and
Enforceability. The execution, delivery, and performance by the Purchaser of this Agreement and the consummation of the Transactions contemplated hereby are within the power of the Purchaser and have been duly authorized by all necessary actions
on the part of the Purchaser. The execution of this Agreement by the Purchaser constitute, or will constitutes, a legal valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except as limited
by bankruptcy, insolvency, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity. 
 3.3 No Consents or Approvals. No consent, approval, authorization or Order of, or registration or filing with, or notice to, any court or Governmental Body having jurisdiction or regulatory
authority over the Purchaser (or any of its properties) is required for (a) the Purchaser’s execution and delivery of this Agreement (and each agreement executed and delivered by it in connection herewith) or (b) the consummation by
the Purchaser of the Transactions contemplated by this Agreement (and each agreement executed and delivered by it 

  
 6 

 
in connection herewith) and to the extent any such consent, approval, authorization, Order, registration, filing or notice was required, it has been obtained, made or given (as applicable) and is
still in full force and effect. 
 3.4 No Broker’s or Finder’s Fee. No Person or Entity acting on behalf of the
Purchaser or any of their affiliates or under the authority of any of them is or will be entitled to any brokers’ or finders’ fee or any other commission or similar fee, directly or indirectly, from the Seller or any of their affiliates in
connection with any of the Transactions contemplated hereby. 
  

	4.	Conditions Precedent to the Purchaser’s Obligation to Close. 

 The Purchaser’s obligation to purchase the Assets and to take the other actions required to be taken by the Purchaser at the Closing is subject to the satisfaction, at or prior to the Closing, of
each of the following conditions (any of which may be waived by the Purchaser, in whole or in part, in writing): 
 4.1
Accuracy of Representations. The representations and warranties of the Seller contained in this Agreement shall have been true when made and at all times after the date when made, to and including the Closing Date, with the same force and effect
as if made on and as of each such times, including the Closing Date, except to the extent that failure of such representations and warranties to be true and correct as of such dates would not have a Material Adverse Effect, and all covenants of the
Seller contained in this Agreement and to be performed at or prior to the Closing shall have been complied with in all material respects. 
 4.2 Performance of Obligations. The Seller shall execute and deliver to the Purchaser such bills of sale, endorsements, assignments and other documents as may (in the reasonable judgment of the
Purchaser or their counsel) be necessary or appropriate to assign, convey, transfer and deliver to the Purchaser good and valid title to the Assets. 
 4.3 Consents. Each of the Consents identified in Schedule 4.3 shall have been obtained and shall be in full force and effect.  

4.4 No Material Adverse Change. There shall have been no material adverse change in the business, condition, assets, liabilities,
operations, financial performance, net income or prospects of the Seller (a “Material Adverse Effect”) since the date of this Agreement, provided, however, that any adverse change arising from or related to: (i) conditions
affecting the Seller’s business or the United States economy generally; (ii) national or international political or social conditions, including the engagement by the United States in hostilities; (iii) financial, banking or
securities markets (including any disruption thereof and any decline in the price of any security or any market index); (iv) changes in GAAP; (v) changes in any Legal Requirements; (vi) any action taken by a party hereto in accordance
with this Agreement; (vii) any existing event or occurrence or circumstance with respect to which the Purchaser has knowledge as of the date hereof; (viii) any adverse change in or effect on the business of the Seller that is cured by the
Seller by the Closing; (ix) the public announcement of the transactions contemplated by this Agreement; (x) any action taken by Purchaser or any of its affiliates or Representatives or (xi) the completion of the transactions
contemplated hereby, shall not be taken into account in determining whether a “Material Adverse Effect” has occurred or would reasonably be expected to occur with respect to such entity. 

  
 7 

	5.	Conditions Precedent to the Seller’s Obligation to Close. 

 The Seller’s obligation to sell the Assets and to take the other actions required to be taken by the Seller at the Closing is subject to the satisfaction, at or prior to the Closing, of each of the
following conditions (any of which may be waived, in whole or in part, in writing): 
 5.1 Accuracy of Representations.
The representations and warranties of the Purchaser contained in this Agreement shall have been true when made and at all times after the date when made, to and including the Closing Date, with the same force and effect as if made on and as of each
such times, including the Closing Date and all covenants of the Purchaser contained in this Agreement and to be performed at or prior to the Closing shall have been complied with in all respects. 

5.2 Purchaser’s Performance. All of the other covenants and obligations that the Purchaser is required to comply with or to
perform pursuant to this Agreement at or prior to the Closing (considered collectively), and each of said covenants and obligations (considered individually), shall have been complied with and performed in all material respects. 

 

	6.	Termination. 

 This
Agreement may be terminated prior to the Closing by the Purchaser or Seller in writing to the other if (a) there is a material breach of any provision in this Agreement by the other Party, or (b) either Party reasonably determines that the
timely satisfaction of any condition set forth in Section 4 have become impossible or impractical (other than as a result of any failure on the part of the Parties to comply with or perform its obligations in this Agreement). 

 

	7.	Post-Closing Covenants. 

 7.1 Further Actions. From and after the Closing Date, the Seller shall cooperate with the Purchaser and the Purchaser’s affiliates and Representatives, and shall execute and deliver such
documents and take such other actions as the Purchaser may reasonably request, for the purpose of evidencing the Transactions and putting the Purchaser in possession and control of the Assets purchased under this Agreement. Without limiting the
generality of the foregoing, from and after the Closing Date, the Seller shall promptly remit to the Purchaser any funds that are received by the Seller and that are included in, or that represent payment of receivables included in, the Assets. The
Seller: (a) hereby irrevocably authorizes the Purchaser, at all times on and after the Closing Date, to endorse in the name of the Seller any check or other instrument that is made payable to the Seller and that represents funds included in, or
that represents the payment of any receivable included in, the Assets; and (b) hereby irrevocably nominates, constitutes and appoints the Purchaser as the true and lawful attorney-in-fact of the Seller (with full power of substitution)
effective as of the Closing Date, and hereby authorizes the Purchaser, in the name of and on behalf of the Seller, to execute, deliver, acknowledge, certify, file and record any document, to institute and prosecute any Proceeding and to take any
other action (on or at any time after the Closing Date) that the Purchaser may reasonably deem appropriate for the purpose of (i) collecting, asserting, enforcing or perfecting any claim, right or interest of any

  
 8 

 
kind that is included in or relates to any of the Assets, (ii) defending or compromising any claim or Proceeding relating to any of the Assets, or (iii) otherwise carrying out or
facilitating any of the Transactions. The power of attorney referred to in the preceding sentence is and shall be coupled with an interest and shall be irrevocable, and shall survive the dissolution or insolvency of the Seller. 

Publicity. The Seller shall ensure that, on and at all times after the Closing Date: (a) no press release or other publicity concerning any
of the Transactions is issued or otherwise disseminated by or on behalf of the Seller without the Purchaser’s prior written consent; (b) the Seller continues to keep the terms of this Agreement and the other Transactional Agreements
strictly confidential; and (c) the Seller keeps strictly confidential, and the Seller does not use or disclose to any other Person, any non-public document to the Purchaser. Notwithstanding the foregoing, the Seller may make any such press
release or announcement and may make any other disclosure regarding this Agreement and the transactions, which it in good faith believes, based on advice of counsel, is necessary in connection with any Legal Requirement. 

7.2 Accounts Receivables. Notwithstanding anything contained in this Agreement to the contrary, Purchaser agrees that all
rights with respect to the receivables set forth on Schedule 1.1(a) shall be allocated between Seller and Purchaser as set forth on Schedule 1.1(a) and that upon Purchaser’s receipt of any payment with respect to any such
receivables, Purchaser shall promptly pay to Seller Seller’s pro rata portion of such payment. 
  

	8.	[Omitted] 

  

	9.	Miscellaneous Provisions. 

9.1 Expenses; Fees. Except as provided in the next sentence, the Purchaser and the Seller shall bear its own expenses incurred in
connection with the Transactions contemplated by this Agreement. Notwithstanding the foregoing, should any party hereto institute any action or proceeding in court or otherwise to enforce or interpret this Agreement by reason of or with respect to
an alleged breach of any provision hereof, the prevailing party shall be entitled to receive from the non-prevailing party such amount as the court may judge to be reasonable attorneys’ and paralegals’ fees for the services rendered to the
prevailing party in such action or proceeding, plus the prevailing party’s costs and expenses therein, regardless of whether such action or proceeding is prosecuted to judgment. 

9.2 Entire Agreement. This Agreement, together with the schedules and exhibits attached hereto, along with the Transaction
Agreements, constitute the entire agreement of the Parties hereto regarding the purchase and sale of the Assets, and all prior agreements, understandings, representations and statements, oral or written, are superseded hereby. 

9.3 Captions. Section captions used in this Agreement are for convenience only, and do not affect the construction of this
Agreement. 
 9.4 Counterpart Execution. This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original and all of which shall together constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Agreement by facsimile transmission shall be effective as delivery of a manually executed
counterpart thereof and shall be deemed an original signature for all purposes. 

  
 9 

 9.5 Notices. Any notice or other communication provided for herein or given hereunder
to a party hereto shall be in writing, and shall be deemed given when personally delivered to a party set forth below or when sent by facsimile providing a transmission confirmation, the next business day after being sent by overnight delivery by a
recognized overnight delivery service, or three (3) days after mailed by first class mail, registered, or certified, return receipt requested, postage prepaid, or when delivered by nationally-recognized overnight delivery service, with proof of
delivery, delivery charges prepaid, in any case addressed as follows: 
  

			
	If to the Seller:	  	Innovaro, Inc.
		  	2109 Palm Avenue
		  	Tampa, Florida 33605
		  	Facsimile: (813) 754-2363
	
	If to the Purchaser:
		  	Strategos, Inc.
		  	35 East Wacker Drive, Ninth Floor
		  	Chicago, Illinois 60601
		  	Facsimile: (312) 655-8334
	
	If to the Strategos Individuals
		
		  	To the address indicated on Exhibit A for each Strategos Individual

 9.6 Severability. If any provision of this Agreement shall for any reason be held to be invalid or
unenforceable, such invalidity or unenforceability shall not affect any other provision of this Agreement, but this Agreement shall be construed as if such invalid or unenforceable provision had never been contained in this Agreement. 

9.7 Further Assurances. At any time or from time to time after the Closing, without further consideration, the Seller shall, at
the request of the Purchaser, execute and deliver such further instruments and documents as the Purchaser may reasonably request as may be reasonably necessary to evidence or effect the consummation of the Transactions contemplated by this
Agreement. 
 9.8 Amendments and Waivers. No amendment of any provision of this Agreement shall be valid unless the same
shall be in writing and signed by the Purchaser and the Seller. No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or
subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence. 

  
 10 

 9.9 Governing Law. This Agreement shall be governed by and interpreted in accordance
with the internal laws of the State of Florida (without reference to conflicts of law principles). 
 9.10 Waiver of Trial by
Jury. THE SELLER AND THE PURCHASER HEREBY EXPRESSLY WAIVE ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING ARISING UNDER OR WITH RESPECT TO THIS AGREEMENT, OR IN ANY WAY CONNECTED WITH, OR RELATED TO, OR
INCIDENTAL TO, THE DEALINGS OF THE PARTIES HERETO WITH RESPECT TO THIS AGREEMENT OR THE TRANSACTIONS RELATED HERETO OR THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND IRRESPECTIVE OF WHETHER SOUNDING IN CONTRACT, TORT, OR
OTHERWISE. THE SELLER AND THE PURCHASER HEREBY AGREE THAT ANY SUCH CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING SHALL BE DECIDED BY A COURT TRIAL WITHOUT A JURY AND THAT ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS
SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE OTHER PARTY OR PARTIES HERETO TO WAIVER OF ITS OR THEIR RIGHT TO TRIAL BY JURY. 
 9.11 Submission to Jurisdiction; Selection of Forum. EACH PARTY HERETO (A) AGREES THAT IT SHALL BRING ANY ACTION OR PROCEEDING IN RESPECT OF ANY CLAIM ARISING OUT OF OR RELATED TO THIS
AGREEMENT OR THE TRANSACTIONS CONTAINED IN OR CONTEMPLATED BY THIS AGREEMENT, WHETHER IN TORT OR CONTRACT OR AT LAW OR IN EQUITY, EXCLUSIVELY IN (I) THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF FLORIDA, (II) IN AN APPROPRIATE
FLORIDA STATE COURT IN TAMPA, FLORIDA (SUCH FEDERAL OR STATE COURT IN TAMPA, FLORIDA IS HEREAFTER REFERRED TO AS THE “CHOSEN COURT”) AND (B) IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE CHOSEN COURT,
(C) WAIVES, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION TO LAYING VENUE IN ANY SUCH ACTION OR PROCEEDING IN THE CHOSEN COURT, (D) WAIVES ANY ARGUMENT THAT THE CHOSEN COURT IS AN INCONVENIENT FORUM OR DOES NOT HAVE JURISDICTION
OVER ANY PARTY THERETO, AND (E) AGREES THAT SERVICE OR PROCESS UPON ANY PARTY IN ANY SUCH ACTION OR PROCEEDING SHALL BE EFFECTIVE IF NOTICE IS GIVEN IN ACCORDANCE WITH SECTION 9.5 OF THIS AGREEMENT. 

9.12 Construction. The Parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an
ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
of the provisions of this Agreement. Any reference to any federal, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word
“including” means “including without limitation”. 

  
 11 

 9.13 No Third-Party Beneficiaries. This Agreement shall not confer any rights or
remedies upon any Person or Entity other than the Parties hereto, the Indemnities, and their respective successors and permitted assigns. 
 9.14 Successor and Assigns. This Agreement shall be binding upon and inure to the benefit of the Parties named herein and their respective successors and permitted assigns. No party may assign its
rights or interests hereunder without providing the other party with prior written notice and receives other parties consent; provided, however, that the Purchaser shall be entitled to assign its rights under this Agreement to an
Entity wholly-owned by the Purchaser. No party may delegate all or any of its obligations or duties hereunder, without the prior written consent of the other party. 
 9.15 [Omitted] 
 9.16 Consequential Damages. IN NO EVENT WILL ANY
PARTY BE LIABLE TO ANY OTHER PARTY, FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SIMILAR INDIRECT DAMAGES (INCLUDING, WITHOUT LIMITATION, LOST PROFITS, CLAIMS FOR SERVICE INTERRUPTION AND CLAIMS FOR LOSS OF DATA) ARISING OUT OF
OR IN CONNECTION WITH THE PURCHASER’S USE, MAINTENANCE OR OPERATION OF ANY OF THE ASSETS FOLLOWING THE CLOSING, IRRESPECTIVE OF THE CAUSE OF ACTION OR THEORY UPON WHICH LIABILITY FOR SUCH DAMAGES MIGHT BE ALLEGED. EXCEPT IN THE EVENT OF FRAUD
BY THE PURCHASER, THE PURCHASER’S TOTAL LIABILITY UNDER THIS AGREEMENT SHALL BE THE PAYMENT OF FUNDS AS REQUIRED PURSUANT TO SECTION 1.2. EXCEPT IN THE EVENT OF FRAUD BY THE SELLER, IN NO EVENT SHALL THE SELLER’S TOTAL LIABILITY
UNDER THIS AGREEMENT EXCEED THE ACTUAL AMOUNT OF THE PURCHASE PRICE ACTUALLY PAID BY THE PURCHASER TO THE SELLER PURSUANT TO SECTION 1.2 OF THIS AGREEMENT. EXCEPT IN THE EVENT OF FRAUD BY A PARTY TO THIS AGREEMENT, THE SELLER AND THE
PURCHASER AGREE THAT THE PROVISIONS OF THIS AGREEMENT SHALL CONSTITUTE THE EXCLUSIVE REMEDY AVAILABLE TO THE SELLER AND THE PURCHASER FOR DAMAGES. THE PARTIES ACKNOWLEDGE THAT THESE LIMITATIONS ON POTENTIAL LIABILITIES WERE AN ESSENTIAL ELEMENT IN
SETTING CONSIDERATION UNDER THIS AGREEMENT. 
 9.17 Non-Disparagement; No-interference. The Parties mutually agree that
they will not publicly make disparaging remarks about the other, such as, by way of example, to members of the media or press, or to any customers or vendors of the Seller or to other third parties. The Strategos Individuals and the Purchaser, its
officers, shareholders, directors and employees further agree not to take any action or make any written or oral statement which is intended to, or in effect, criticizes, denigrates or disparages the goodwill, business, services or reputation of the
Seller, or any of its shareholders, officers, directors, affiliates or advisors, or otherwise to intimidate, harass or otherwise interfere with any of the foregoing persons. 
 9.18 No Survival of Representations and Warranties. None of the representations and warranties in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Closing
or the termination of this Agreement. 
 [Signature Page Follows] 

  
 12 

 IN WITNESS WHEREOF, the Purchaser, the Seller and the Strategos Individuals have caused this
Agreement to be executed as of the day and year first above written. 
  

			
	SELLER:
	
	INNOVARO, INC.
		
	By:	 	 /s/ Asa Lanum

		
	Its:	 	 Chief Executive Officer

	
	PURCHASER:
	
	STRATEGOS, INC.
		
	By:	 	 /s/ Gary Getz

		
	Its:	 	 President

  
 13 

 
			
	STRATEGOS INDIVIDUALS
		
	By:	 	 /s/ Gary Getz

 
			
		
	Name:	 	 Gary Getz

 
			
		
	By:	 	 /s/ Ian Pallister

 
			
		
	Name:	 	 Ian Pallister

  
 14 

 EXHIBIT A 
 STRATEGOS INDIVIDUALS 
 Gary Getz 

275 Escobar Road 
 Portola Valley, CA 94028 USA

 Phone: (650) 854-0401 

Facsimile: (650) 854-0491 
 e-mail:
ggetz@strategos.com 
 Ian Pallister 

Auenstrasse 35 
 85737 Ismaning 

Deutschland 
 Phone: +49 171 209 5670 

e-mail: ian.pallister@strategos.com 

  
 15 

 EXHIBIT B 
 CERTAIN DEFINITIONS 
 For purposes of the
Agreement (including this Exhibit B): 
 Agreement. “Agreement” shall mean the Asset
Purchase Agreement to which this Exhibit B is attached (including any Schedule annexed hereto), as it may be amended from time to time. 
 Comparable Entities. “Comparable Entities” shall mean Entities (other than the Seller) that are engaged in businesses similar to the business of the Seller. 

Consent. “Consent” shall mean any approval, consent, ratification, permission, waiver or authorization
(including any Governmental Authorization). 
 Contract. “Contract” shall mean any written, oral,
implied or other agreement, contract, understanding, arrangement, instrument, note, guaranty, indemnity, representation, warranty, deed, assignment, power of attorney, certificate, purchase order, work order, insurance policy, benefit plan,
commitment, covenant, assurance or undertaking of any nature. 
 Damages. “Damages” shall include
any loss, damage, injury, decline in value, lost opportunity, Liability, claim, demand, settlement, judgment, award, fine, penalty, Tax, fee (including any legal fee, expert fee, accounting fee or advisory fee), charge, cost (including any cost of
investigation) or expense of any nature. 
 Encumbrance. “Encumbrance” shall mean any material
lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, equity, trust, equitable interest, claim, preference, right of possession, lease, tenancy, license, encroachment, covenant, infringement, interference, Order, proxy,
option, right of first refusal, preemptive right, community property interest, legend, defect, impediment, exception, reservation, limitation, impairment, imperfection of title, condition or restriction of any nature (including any restriction on
the transfer of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset). 
 Entity. “Entity” shall mean any corporation (including any non-profit corporation), general partnership, limited partnership, limited liability partnership, joint venture,
estate, trust, cooperative, foundation, society, political party, union, company (including any limited liability company or joint stock company), firm or other enterprise, association, organization or entity. 

Excluded Assets. “Excluded Assets” shall mean those assets not used in the Consulting Business and
including, without limitation, the assets identified on Exhibit C (to the extent owned by the Seller on the Closing Date). 

Governmental Authorization. “Governmental Authorization” shall mean any: (a) permit, license,
certificate, franchise, concession, approval, consent, ratification, permission, 

  
 16 

 
clearance, confirmation, endorsement, waiver, certification, designation, rating, registration, qualification or authorization issued, granted, given or otherwise made available by or under the
authority of any Governmental Body or pursuant to any Legal Requirement; or (b) right under any Contract with any Governmental Body. 
 Governmental Body. “Governmental Body” shall mean any: (a) nation, principality, state, commonwealth, province, territory, county, municipality, district or other
jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or quasi-governmental authority of any nature (including any governmental division, subdivision, department, agency, bureau,
branch, office, commission, council, board, instrumentality, officer, official, representative, organization, unit, body or Entity and any court or other tribunal); (d) multi-national organization or body; or (e) individual, Entity or body
exercising, or entitled to exercise, any executive, legislative, judicial, administrative, regulatory, police, military or taxing authority or power of any nature. 
 Intellectual Property. “Intellectual Property” shall mean and include all algorithms, application programming interfaces, apparatus, assay components, biological materials,
cell lines, clinical data, chemical compositions or structures, circuit designs and assemblies, databases and data collections, diagrams, formulae, gate arrays, IP cores, inventions (whether or not patentable), know-how, logos, marks (including
brand names, product names, logos, and slogans), methods, network configurations and architectures, net lists, photomasks, processes, proprietary information, protocols, schematics, specifications, software, software code (in any form including
source code and executable or object code), subroutines, test results, test vectors, user interfaces, techniques, URLs, web sites, works of authorship, and other forms of technology (whether or not embodied in any tangible form and including all
tangible embodiments of the foregoing such as instruction manuals, laboratory notebooks, prototypes, samples, studies, and summaries). 
 Intellectual Property Rights. “Intellectual Property Rights” shall mean and include all rights of the following types, which may exist or be created under the laws of any
jurisdiction in the world: (a) rights associated with works of authorship, including exclusive exploitation rights, copyrights, moral rights, and mask works; (b) trademark and trade name rights and similar rights; (c) trade secret
rights; (d) patents and industrial property rights; (e) other proprietary rights in Intellectual Property of every kind and nature; and (f) all registrations, renewals, extensions, continuations, divisions, or reissues of, and
applications for, any of the rights referred to in clauses (a) through (e) above. 
 Knowledge.
“Knowledge” shall mean that an individual shall be deemed to have “Knowledge” about a particular fact or other matter if: (a) such individual is actually aware of such fact or other matter; or (b) a
prudent individual should have known such fact or other matter under the circumstances. Sellers shall be deemed to have “Knowledge” of a particular fact or other matter if Chief Executive Officer, Asa Lanum, or Chief Financial Officers,
Carol Wright, has Knowledge of such fact or other matter. 
 Legal Requirement. “Legal
Requirement” shall mean any federal, state, local, municipal, foreign or other law, statute, legislation, constitution, principle of common law, resolution, ordinance, code, edict, decree, proclamation, treaty, convention, rule,
regulation, 

  
 17 

 
ruling, directive, pronouncement, requirement, specification, determination, decision, opinion or interpretation issued, enacted, adopted, passed, approved, promulgated, made, implemented or
otherwise put into effect by or under the authority of any Governmental Body. 
 Liability.
“Liability” shall mean any debt, obligation, duty or liability of any nature (including any unknown, undisclosed, unmatured, unaccrued, unasserted, contingent, indirect, conditional, implied, vicarious, derivative, joint,
several or secondary liability), regardless of whether such debt, obligation, duty or liability would be required to be disclosed on a balance sheet prepared in accordance with generally accepted accounting principles and regardless of whether such
debt, obligation, duty or liability is immediately due and payable. 
 License Agreement. “License
Agreement” shall mean that certain Technology License Agreement dated as of October 2, 2012 by and between the Purchaser and the Seller. 
 Order. “Order” shall mean any: (a) order, judgment, injunction, edict, decree, ruling, pronouncement, determination, decision, opinion, verdict, sentence, subpoena,
writ or award issued, made, entered, rendered or otherwise put into effect by or under the authority of any court, administrative agency or other Governmental Body or any arbitrator or arbitration panel; or (b) Contract with any Governmental
Body entered into in connection with any Proceeding. 
 Ordinary Course of Business. An action taken by or on behalf of
the Seller shall not be deemed to have been taken in the “Ordinary Course of Business” unless: 
 (a) such action is recurring in nature, is similar in nature and magnitude to actions customarily taken, is consistent with the past practices of the Seller and is taken in the ordinary course of the
normal day-to-day operations of the Seller; 
 (b) such action is taken in accordance with sound and prudent
business practices; and 
 (c) such action is not required to be authorized by the shareholders of the Seller,
the board of directors of the Seller or any committee of the board of directors of the Seller and does not require any other separate or special authorization of any nature. 
 Person. “Person” shall mean any individual, Entity or Governmental Body. 
 Proceeding. “Proceeding” shall mean any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate
proceeding and any informal proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Body or any arbitrator or
arbitration panel. 
 Purchased IP. “Purchased IP” shall mean the Intellectual Property and
Intellectual Property Rights identified in Schedule 1.1(e) and the related goodwill of the Seller. 
 Registered IP.
“Registered IP” shall mean all Intellectual Property Rights that are registered, filed, or issued under the authority of any Governmental Body, including all patents, registered copyrights, registered mask works, and
registered trademarks and all applications for any of the foregoing. 

  
 18 

 Representatives. “Representatives” shall mean officers,
directors, employees, agents, attorneys, accountants, advisors and representatives. 
 Seller Contract.
“Seller Contract” shall mean those contracts set forth on Schedule 1.1(f). 
 Seller IP.
“Seller IP” shall mean (a) all Intellectual Property Rights in or pertaining to the Seller Products or methods or processes used to manufacture the Seller Products related to the Purchased IP, and (b) all other
Intellectual Property Rights owned by or exclusively licensed to the Seller related to the Purchased IP. 
 Seller IP
Contract. “Seller IP Contract” shall mean any Contract to which the Seller is a party or by which the Seller is bound, that contains any assignment or license of, or covenant not to assert or enforce, any Purchased IP or
that otherwise relates to any Purchased IP. 
 Seller Product. “Seller Product” shall mean any
product or service from the Purchased IP designed, developed, manufactured, marketed, distributed, provided, licensed, or sold at any time by the Seller. 
 Tax. “Tax” shall mean any tax (including any income tax, franchise tax, capital gains tax, estimated tax, gross receipts tax, value-added tax, surtax, excise tax, ad valorem
tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, occupation tax, inventory tax, occupancy tax, withholding tax or payroll tax), levy, assessment, tariff, impost, imposition, toll, duty (including any customs duty),
deficiency or fee, and any related charge or amount (including any fine, penalty or interest), that is, has been or may in the future be (a) imposed, assessed or collected by or under the authority of any Governmental Body, or (b) payable
pursuant to any tax-sharing agreement or similar Contract. 
 Transactional Agreements. “Transactional
Agreements” shall mean: (a) the Agreement; (b) the License Agreement; (c) the Separation Agreements; and (d) the Closing Certificate. 
 Transactions. “Transactions” shall mean (a) the execution and delivery of the respective Transactional Agreements, and (b) all of the transactions contemplated by
the respective Transactional Agreements, including: (i) the sale of the Assets by the Seller to the Purchaser in accordance with the Agreement; and (ii) the performance by the Seller, the Purchaser and the Strategos Individuals of their
respective obligations under the Transactional Agreements, and the exercise by the Seller, the Strategos Individuals and the Purchaser of their respective rights under the Transactional Agreements. 

  
 19 

 EXHIBIT C 
 Additional Excluded Assets 
  

	1.	All Intellectual Property Rights and Intellectual Property related to the consulting business except for only those Intellectual Property and Intellectual Property
Rights expressly set out in Schedule 1.1(e). 

  

	2.	All assets of Seller not specifically or expressly identified in this Agreement as being sold, assigned, transferred, conveyed and delivered to Purchaser.

  

	3.	The Seller Receivables set forth on Schedule 1.1(a). 

  
 20 

 SCHEDULE 1.1(A) 

Accounts Receivable 
  

													
	 	  	Amount of Receivable	 	  	Amount to be Paid to
Seller by Purchaser
(the
“Seller
Receivables”)	 	  	Amount to be Retained
by Purchaser	 
	 Altria-02
	  	$	249,919.57	  	  	$	28,107.57	  	  	$	175,000.00 fees plus	  
		  				  				  	$	46,812.00 expenses	  
	 Syngenta-02
	  	$	47,525.14	  	  	$	2,841.14	  	  	$	42,000.00 fees plus	  
		  				  				  	$	2,684.00 expenses	  

  
 21 

 SCHEDULE 1.1(C) 

Tangible assets 
 All
equipment, materials, supplies, furniture, and other tangible assets of the Seller located at the current Chicago, Illinois, Strategos office. 

Company-owned personal computers over 12 months of age in the possession of individual Strategos members. 

  
 22 

 SCHEDULE 1.1(E) 

Intellectual Property and Intellectual Property Rights 
 1. Strategos brand name and logo; including, without limitation: 
  

	 	A.	“STRATEGOS” – US – Reg. No. 2,124,308 

  

	 	B.	“STRATEGOS” – Australia – Reg. No. 731326 (remains in the original Strategos’ name and would need to be transferred from Strategos to
Innovaro to Strategos and can be done post closing.) 

  

	 	C.	“STRATEGOS” – United Kingdom – Reg. No. 2137262 

  

	 	D.	“STRATEGOS” (Logo) – United Kingdom – Reg. No. 2137264 

 2. Strategos customer list, including both current and formerly active clients, and other address lists of prospective clients and commercial contacts 

3. The following web domains: 
  

	 	a.	www.strategos.com; 

  

	 	b.	www.discoveryspace.com; 

  

	 	c.	www.innovationtothecore.com; and 

  

	 	d.	other web domains and addresses as mutually agreed 

  
 23 

 SCHEDULE 1.1(F) 

Contracts 
  

	1.	Project Agreement, dated March 1, 2012 by and between Altria Client Services, Inc. and Strategos, a Division of Innovaro, Inc. 

 

	2.	Master Services Agreement, dated March 1, 2012 by and between Altria Client Services, Inc. and Strategos, a Division of Innovaro, Inc. 

 

	3.	Service Provider Agreement, dated February 1, 2012 by and between Syngenta Crop Protection AB, a Swiss corporation and Strategos, a Division of Innovaro, Inc.

  
 24 

 SCHEDULE 1.1(G) 

Governmental Consents 

See Schedule 1.1(e) 

  
 25 

 SCHEDULE 2.6(B)(III) 

Action, Filing, and Payment Required within 120 days after the date of this Agreement in order to maintain Seller IP 

None 

  
 26 

 SCHEDULE 2.6(C) 

Actual, Alleged, or Suspected Infringement or Misappropriation of any Seller IP 

None 

  
 27 

 SCHEDULE 4.3 
 Consents (other than Governmental Consents) 
 [insert] 

  
 28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]